"OwnerId","Approval_Details__c","Auto_Adjudication_Requirements__c","Auto_Push_to_Pharmanet__c","Auto_Validate_Patient__c","Auto_Validate_Provider__c","Brand_Drug_Name__c","CDEC_Recommendation__c","Criteria_Website__c","DBC_R_R__c","Drug_Code__c","Drug_Review_Results__c","Form__c","Health_Canada_monograph__c","PharmaNet_RDP_code__c","Pharmacist_Notes__c","Practitioner_Exemptions__c","Special_Notes__c","Strength__c","Tech_Sheet__c","Name"
"00G5W000000MXTvUAO","","","true","true","true","","","","","100extrabgts","","test strips","","9901-0245","","","Stamp for MIR:<br><br><strong>Please clarify below how the patient satisfies PharmaCare criteria below:</strong><br>┬á
<p>Patient has diabetes, is not on insulin OR patient has diabetes, is on insulin and is using a Glucose Monitoring System, and is experiencing at least one of the following:<br>┬á</p>

<p>Γûí┬á┬áNot meeting glycemic targets, as determined by physician, for 3 months or more.</p>

<p>Γûí┬á┬áAcute illness or co-morbidities that may impact blood glucose control.</p>

<p>Γûí┬á┬áChanges in drug therapy that may impact blood glucose control (e.g. starting or stopping hypo or hyperglycemic inducing medications,┬ádrug-to-drug or drug-to-disease interactions).</p>

<p>Γûí┬á┬áOccupations where hypoglycemia presents a significant safety risk (e.g., pilots, air traffic controllers, commercial drivers, etc.).</p>

<p>Γûí┬á┬áGestational diabetes.</p>","","","100 extra blood glucose test strips"
"00G5W000000MXTvUAO","Approved for fully covered, reference PPls: pantoprazole magnesium and rabeprazole. This also includes partial coverage of non-reference PPls: esomeprazole, lansoprazole, omeprazole, pantoprazole sodium.","Patient validated with EMPI Prescriber validated with PNET Diagnosis not equal to &quot;Other&quot; OR &quot;H. Pylori&quot;","true","true","true","Tecta and generics; fully covered reference PPI","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/proton-pump-inhibitors-pantoprazole-magnesium","","1PPIpant","","tablet","","9901-0078","Important info here","Gastroenterologists","<p>Forward to pharmacist:</p>

<p>-patients on transplant or antiretroviral medications</p>

<p>-requests specifically indicating brand name<br><br><strong>2nd Tier PPI. If Golden contradicts 1st tier PPI trials stated by a prescriber (++remove the drug confirmed on golden++), MIR:</strong><br><br>┬á</p>

<p><strong>xxxxx</strong> (non reference PPIs) <strong>-</strong><strong> </strong><strong>More Information Required</strong></p>

<p>Not approved based upon available information. Available PharmaCare records were unable to verify previous fills of pantoprazole magnesium/rabeprazole. For further consideration, please specify dates, dosages, and source(s) of medication. Please note: samples will not be accepted as a trial. Thank you</p>

<p>┬á</p>

<p><strong>Pantoprazole Magnesium/Rabeprazole </strong>(reference PPIs)<strong>- Approved </strong></p>

<p>Approved for fully covered, reference PPIs: pantoprazole magnesium and rabeprazole. This also includes partial coverage of non-reference PPIs: esomeprazole, lansoprazole, omeprazole, pantoprazole sodium.</p>

<p><br>┬á</p>","40mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","pantoprazole magnesium"
"00G5W000000MXTvUAO","Approved for fully covered, reference PPls: pantoprazole magnesium and rabeprazole. This also includes partial coverage of non-reference PPls: esomeprazole, lansoprazole, omeprazole, pantoprazole sodium.","Patient validated with EMPI
Prescriber validated with PNET
Diagnosis not equal to &quot;Other&quot; OR &quot;H. Pylori&quot;","true","true","true","Pariet and generics; non-reference PPI","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/proton-pump-inhibitor-rabeprazole","","1PPIrabe","","tablet","","9901-0078","Important details here","Gastroenterologists","<p>Forward to pharmacist:</p>

<p>-patients on transplant or antiretroviral medications</p>

<p>-requests specifically indicating brand name</p>","10mg and 20mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","rabeprazole"
"00G5W000000MXTvUAO","Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.","","false","false","false","Nexium; non-reference PPI","","","","2PPIesom","","tablet","","9901-0054","","","<p>Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.</p>","20mg and 40mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","esomeprazole"
"00G5W000000MXTvUAO","Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.","","false","true","true","Prevacid and generics; non-reference PPI","","","","2PPIlans","","tablet","","9901-0054","","Gastroenterologists","<p>Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.</p>","15mg and 30mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","lansoprazole"
"00G5W000000MXTvUAO","Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.","","false","false","false","Losec and generics; non-reference PPI","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/proton-pump-inhibitors-omeprazole","","2PPIomep","","tablet","","9901-0054","","Gastroenterologists","<p>Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.</p>","20mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","omeprazole"
"00G5W000000MXTvUAO","Approved for full coverage of PharmaCare eligible formulations of pantoprazole Mg, rabeprazole, esomeprazole, lansoprazole, omeprazole and pantoprazole sodium.","","false","false","false","Pantoloc and generics; non-reference PPI","","","","2PPIpant","","tablet","","9901-0054","","Gastroenterologists","","40mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/PPIUpdatedTechSheet.pdf","pantoprazole sodium"
"00G5W000000MXTiUAO","Approved abatacept _","","false","true","true","Orencia","","","","abatacept","","Injectable","","9901-0151","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved for the following weight based doses: 500 mg dose for patients weighing less than 60 kg, 750 mg dose for patients weighing 60 to 100 kg, and a 1000 mg dose for patients weighing more than 100 kg.</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved for these IV doses at 0, 2 and 4 weeks for new treatment starts, and then every 4 weeks thereafter.┬á</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">┬á</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Please note that claims will be monitored and subject to review.┬áFor changes in dosage regimens, please submit renewal application for review by Committee.┬áThank you.</span></p>","250mg/15mL, 125mg/mL","","abatacept"
"00G5W000000MXTvUAO","","","false","false","false","Dysport","","","","abobotulinum","","Injectable","","9901-0111","","","<p>For consideration of coverage for abobotulinum toxin, please specify if patientΓÇÖs diagnosis requiring use is cervical dystonia OR focal spasticity, as per attached criteria. Thank you.</p>","300 units/vial, 500 units/vial","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/abobotulinum%20toxin.pdf","abobotulinum"
"00G5W000000MXTuUAO","","","false","false","false","Cibinqo","https://www.cadth.ca/sites/default/files/DRR/2022/SR0686REC-Cibinqo_Final.pdf","","","abrocitinib","https://www.cadth.ca/sites/default/files/DRR/2022/SR0686REC-Cibinqo_Final.pdf","","https://pdf.hres.ca/dpd_pm/00071453.PDF","9901-0444","","","","50mg, 100mg, 200mg","","abrocitinib"
"00G5W000000MXTvUAO","Acamprosate is a regular Fair PharmaCare benefit (effective April 20, 2023). A Special Authority application is not needed for coverage. Please note, medications are subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price. Thank you. 
https://pharmacareformularysearch.gov.bc.ca/faces/Search.xhtml","","false","false","false","Campral","","","","acamprosate","","tablet","","9901-0143","","","","333 mg","","acamprosate"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability. Thank you","","false","false","false","Glucobay","","","","acarbose","","tablet","https://pdf.hres.ca/dpd_pm/00010798.PDF","9901-0175","If approving, can do 1 year initial coverage, then indef. renewal if benefit shown.","","","100 mg","","acarbose"
"00G5W000000MXTvUAO","","","false","false","false","Capoten and generics","","","","ACEIcapt","","tablet","","0024-0100","","","<p><span style=""font-size: 13.3333px; color: rgb(62, 62, 60);"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","6.25, 12, 25, 50, 100mg non-reference ACE-Inhibitor","","captopril"
"00G5W000000MXTvUAO","","","false","false","false","Inhibace, Inhibace Plus and generics","","","","ACEIcila","","tablet","","9901-0100","","","<p><span style=""font-size: 13.3333px; color: rgb(62, 62, 60);"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","1mg, 2.5mg, 5mg non-reference ACE-Inhibitor","","cilazapril"
"00G5W000000MXTvUAO","","","false","false","false","Lotensin and generics","","","","ACEIdena","","tablet","","0024-0100","","","<p><span style=""font-size: 10pt;"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","5mg, 10mg, 20mg non-reference ACE-Inhibitor","","benazepril"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril.","","false","false","false","Vasotec/Vaseretic and generics","","","","ACEIenap","","tablet","","0024-0100","","","<p><span style=""color: #3e3e3c; font-size: 13.3333px;"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","2.5, 5, 10 ,20mg non-reference ACE-Inhibitor","","enalapril"
"00G5W000000MXTvUAO","","","false","false","false","Monopril and generics","","","","ACEIfosi","","tablet","","0024-0100","","","<p><span style=""font-size: 13.3333px; color: rgb(62, 62, 60);"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","10mg, 20mg non-reference ACE-Inhibitor","","fosinopril"
"00G5W000000MXTvUAO","","","false","false","false","Zestril/Zestoretic and generics","","","","ACEIliso","","tablet","","0024-0100","","","<p><span style=""font-size: 13.3333px; color: rgb(62, 62, 60);"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","5, 10, 20mg non-reference ACE-Inhibitor","","lisinopril"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril.



*Note: Coversyl Plus (perindopril + indapamide) combination tablets are not eligible for PharmaCare coverage. (indapamide is eligible as a separate Special Authority).","","true","true","true","Coversyl and generics","","","","ACEIperi","","tablet","","0024-0100","","","<p><span style=""font-size: 13.3333px; color: rgb(62, 62, 60);"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril.</span></p><p><br></p><p><span style=""font-size: 13px;"">*Note: Coversyl Plus (perindopril + indapamide) combination tablets are not eligible for PharmaCare coverage. (indapamide is eligible as a separate Special Authority).</span></p>","2mg, 4mg, 8mg non-reference ACE-Inhibitor","","perindopril"
"00G5W000000MXTvUAO","","","false","false","false","Accupril/Accuretic and generics","","","","ACEIquin","","tablet","","0024-0100","","","<p><span style=""color: #172b4d; font-size: 11pt;"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril.</span></p>","5, 10, 20, 40mg non-reference ACE-Inhibitor","","quinapril"
"00G5W000000MXTvUAO","","","false","false","false","Mavik and generics","","","","ACEItran","","tablet","","0024-0100","","","<p><span style=""color: rgb(23, 43, 77); font-size: 11pt;"">This approval includes PharmaCare eligible strengths and formulations (+/- hctz) of: benazepril, captopril, cilazapril, enalapril, fosinopril, lisinopril, perindopril, quinapril and trandolapril</span></p>","0.5mg, 1mg, 2mg, 4mg non-reference ACE-Inhibitor","","trandolapril"
"00G5W000000MXTvUAO","","","true","true","true","Tylenol and generics","","","","acetaminophen","","tablet","","9901-0034","test","","","500mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/acetaminophen%20500mg.pdf","acetaminophen 500mg"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific details.","","false","false","false","Tylenol and generics","","","","acetaminophen325mg","","tablet","","9901-0274","You can approve the 325mg tablet only when there is
an indication that it is for OA and there is justification that
the 500mg is not appropriate for the patient. For example if
the patient was frail and elderly and 500mg would be too much.","","","325 mg","","acetaminophen 325mg"
"00G5W000000MXTiUAO","Approved biosimilar adalimumab 40 mg every _ days","","false","true","true","adalimumab (Amgevita* CF, Idacio, Hadlima, Hulio CF, Hyrimoz*) 40mg/0.8mL, *20mg/0.4mL","","","","adalimumab","","Injectable","","9901-0372","To generate a second payload for the 80mg dose, find a request detail for initial/renewal and edit it to add the word ""increase"" at the end of whatever is already present in the field.","","<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">For patients newly starting adalimumab for ulcerative colitis or CrohnΓÇÖs disease:</span></p>

<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">Approved for 160 mg dose on week 1, 80 mg dose on week 2 for initial loading doses, then 40 mg every 2 weeks thereafter during the approval period. </span></p>

<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">┬á</span></p>

<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">For patients with plaque psoriasis newly starting adalimumab:</span></p>

<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">Approved for an 80 mg single dose for their initial loading dose, then approved for 40 mg doses every 14 days thereafter (during the approval period).<br><br>HS:┬á</span>Approved biosimilar adalimumab 160 mg, then 80 mg dose on day 14, then 40 mg on day 28, then 40mg weekly</p>

<p>┬á</p>

<p><span style=""font-family: Calibri,sans-serif; font-size: 11pt;"">Please note that claims will be monitored and subject to review.┬áFor changes in dosage regimens, please submit renewal application for review by Committee.┬áThank you.</span></p>","40mg/0.8mL, 20mg/0.4mL","","adalimumab (biosimilars)"
"00G5W000000MXTvUAO","Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.","","false","false","false","Adderall-type - generic only","","","","ADHDamph","","tablet","","9901-0092","","","<p><span style=""font-size: 13px;"">Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.┬á</span></p><p><br></p><p><strong><u>MIR/Not Approved Responses:</u></strong></p><p><br></p><p><strong style=""font-size: 16px;""><u>Missing dx:</u></strong></p><p><span style=""font-size: 16px;"">Please specify if diagnosis requiring use includes ADHD.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Missing drug trial:</u></strong></p><p><span style=""font-size: 16px;"">Please specify dose, duration and results of trial with methylphenidate IR/SR (ie. Ritalin-type methylphenidate) or dexamphetamine IR/SR, OR provide rationale to avoid trial. Please note, Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><br></p><p><strong style=""font-size: 16px;""><u>Previously trialed med specified is a long acting stimulant:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - Coverage requires previous trial of a regular benefit stimulant (ie. Ritalin-type methylphenidate IR/SR or dextroamphetamine IR/SR). Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Have checked off a med, but no results specified:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Please specify dose, duration, and results of the noted medication that was previously trialed.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>They claim the patient had the required med trial, but no fills are on PharmaNet:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - PharmaNet records dating back to XXX do not show any previous fills of [specified med] for this patient</span></p><p><span style=""font-size: 16px;"">in BC. Patient does not appear to have had the required previous medication trial. For further consideration, please</span></p><p><span style=""font-size: 16px;"">specify date of trial and source of medication.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Contraindication to short acting stimulants listed as risk of diversion on campus:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - Attendance at a post secondary institution is not accepted as a blanket rationale for avoiding short</span></p><p><span style=""font-size: 16px;"">acting stimulants.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Patient has filled an IR/SR product, but it at the same time or after they started a long acting product:</u></strong></p><p><span style=""font-size: 16px;"">Send to pharmacist</span></p>","","","amphetamine mixed salts XR"
"00G5W000000MXTvUAO","","","false","false","false","Strattera-type - generics only","","","","ADHDatom","","tablet","","9901-0091","","","","10mg, 18mg, 25mg, 40mg. 60mg, 80mg, 100mg","","atomoxetine"
"00G5W000000MXTvUAO","Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.","","false","false","false","Vyvanse","","","","ADHDlisd","","tablet","","9901-0092","","","<p><span style=""font-size: 13px;"">Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.┬á</span></p><p><br></p><p><strong style=""font-size: 14px;""><u>MIR/Not Approved Responses:</u> </strong></p><p><br></p><p><strong style=""font-size: 16px; background-color: rgb(255, 255, 255);""><u>Missing dx:</u></strong></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Please specify if diagnosis requiring use includes ADHD.</span></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>Missing drug trial:</u></strong></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Please specify dose, duration and results of trial with methylphenidate IR/SR (ie. Ritalin-type methylphenidate) or dexamphetamine IR/SR, OR provide rationale to avoid trial. Please note, Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>Previously trialed med specified is a long acting stimulant:</u></strong></p><p><br></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Not approved - Coverage requires previous trial of a regular benefit stimulant (ie. Ritalin-type methylphenidate IR/SR or dextroamphetamine IR/SR). Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>Have checked off a med, but no results specified:</u></strong></p><p><br></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Please specify dose, duration, and results of the noted medication that was previously trialed.</span></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>They claim the patient had the required med trial, but no fills are on PharmaNet:</u></strong></p><p><br></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Not approved - PharmaNet records dating back to XXX do not show any previous fills of [specified med] for this patient</span></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">in BC. Patient does not appear to have had the required previous medication trial. For further consideration, please</span></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">specify date of trial and source of medication.</span></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>Contraindication to short acting stimulants listed as risk of diversion on campus:</u></strong></p><p><br></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Not approved - Attendance at a post secondary institution is not accepted as a blanket rationale for avoiding short</span></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">acting stimulants.</span></p><p><br></p><p><strong style=""background-color: rgb(255, 255, 255); font-size: 16px;""><u>Patient has filled an IR/SR product, but it at the same time or after they started a long acting product:</u></strong></p><p><span style=""background-color: rgb(255, 255, 255); font-size: 16px;"">Send to pharmacist</span></p>","10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 70mg","","lisdexamfetamine capsules"
"00G5W000000MXTvUAO","Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.","","false","false","false","Concerta and generics","","","","ADHDmeth","","tablet","","9901-0092","","Pediatricians, child psychiatrists, and general practitioners","<p><span style=""font-size: 13px;"">Coverage includes generics of methylphenidate ER (Concerta-type) and mixed-amphetamine salts ER, as well as lisdexamfetamine capsules.┬á</span></p><p><br></p><p><strong><u>MIR/Not Approved Responses:</u></strong></p><p><br></p><p><strong style=""font-size: 16px;""><u>Missing dx:</u></strong></p><p><span style=""font-size: 16px;"">Please specify if diagnosis requiring use includes ADHD.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Missing drug trial:</u></strong></p><p><span style=""font-size: 16px;"">Please specify dose, duration and results of trial with methylphenidate IR/SR (ie. Ritalin-type methylphenidate) or dexamphetamine IR/SR, OR provide rationale to avoid trial. Please note, Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><br></p><p><strong style=""font-size: 16px;""><u>Previously trialed med specified is a long acting stimulant:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - Coverage requires previous trial of a regular benefit stimulant (ie. Ritalin-type methylphenidate IR/SR or dextroamphetamine IR/SR). Previous trials of methylphenidate ER (eg. Concerta, Biphentin, Foquest) or long-acting amphetamines (eg. Adderall, Vyvanse) are not accepted as an alternative.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Have checked off a med, but no results specified:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Please specify dose, duration, and results of the noted medication that was previously trialed.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>They claim the patient had the required med trial, but no fills are on PharmaNet:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - PharmaNet records dating back to XXX do not show any previous fills of [specified med] for this patient</span></p><p><span style=""font-size: 16px;"">in BC. Patient does not appear to have had the required previous medication trial. For further consideration, please</span></p><p><span style=""font-size: 16px;"">specify date of trial and source of medication.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Contraindication to short acting stimulants listed as risk of diversion on campus:</u></strong></p><p><br></p><p><span style=""font-size: 16px;"">Not approved - Attendance at a post secondary institution is not accepted as a blanket rationale for avoiding short</span></p><p><span style=""font-size: 16px;"">acting stimulants.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Patient has filled an IR/SR product, but it at the same time or after they started a long acting product:</u></strong></p><p><span style=""font-size: 16px;"">Send to pharmacist</span></p>","18mg, 27mg, 36mg, 54mg","","methylphenidate ER"
"00G5W000000MXTvUAO","","","true","false","false","Aricept and generics","","","","ADTIdone","","tablet","","9901-0087","","","","5mg, 10mg","","donepezil"
"00G5W000000MXTvUAO","","","false","false","false","Reminyl ER and generics","","","","ADTIgala","","tablet","","9901-0085","","","","8mg, 16mg, 24mg","","galantamine"
"00G5W000000MXTvUAO","","","false","false","false","Exelon","","","","ADTIriva","","tablet","","9901-0086","","","","1.5mg, 3mg, 4.5mg, 6mg","","rivastigmine oral tablets"
"00G5W000000MXTxUAO","","","true","true","true","Pradax","","","","afibdaba","","tablet","","9901-0192","","","<p>Exceptional coverage provided at this time due to ongoing COVID-19 impact on INR testing and accessibility to medical services.</p>","110mg, 150mg","","dabigatran"
"00G5W000000MXTxUAO","Reimbursement is only provided for drug prepared by select compounding pharmacies and distributed through Provincial Health Services Authority (PHSA). Please email psp@phsa.ca for details on obtaining drug supply.

Patients who meet coverage criteria will be approved for both aflibercept and ranibizumab. However, only one can be used at a time per affected eye. In cases where patients are using both aflibercept and ranibizumab at the same time for the same affected eye, coverage will be discontinued.","","true","true","true","Eylea aliquoted (compounded) syringe","","","","afliberceptCMPD","","","","9901-0455","","<p>None</p>","","2 mg/0.05 mL","","aflibercept aliquoted syringe"
"00G5W000000MXTxUAO","","","false","false","false","Aggrenox","","","","aggrenox","","tablet","","9901-0203","","","","25/200mg","","ASA/dipyridamole"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada. A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Albenza","","","","albendazole","","","","66127948","","","","400 mg","","albendazole"
"00G5W000000MXTpUAO","","","false","false","false","Lemtrada","https://www.cadth.ca/sites/default/files/cdr/complete/cdr-complete-SR0405-Lemtrada-June-22-2015.pdf","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-alemtuzumab","DNL at submitted price","alemtuzumab","https://fmdb.hlth.gov.bc.ca/AttachmentRetrievalServlet?sub=7359","i.v. infusion","https://pdf.hres.ca/dpd_pm/00060831.PDF","9901-0296","high cost drug = 5%","<p>None</p>","","12mg/1.2mL","","alemtuzumab"
"00G5W000000MXTvUAO","Alendronate 10mg, 70mg and alendronate + vitamin D 70/5600IU are PharmaCare regular benefits as of Aug 29, 2024. Special Authority submission is not required. Thank you.","","true","true","true","Fosamax and generics","","","","alenalen","","tablet","","9901-0099","","","<p>Alendronate 10mg, 70mg and alendronate + vitamin D 70/5600IU<span style=""font-size: 14px;""> are PharmaCare regular benefits as of Aug 29, 2024. Special Authority submission is not required. Thank you.</span></p>","10mg & 70mg; 70 mg/5600 IU","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/alendronate%2010mg%20+%2070mg.pdf","alendronate 10mg & 70mg; 70 mg/5600 IU"
"00G5W000000MXTvUAO","Risedronate 5mg and 35mg (non-DR formulation) is a PharmaCare regular benefit as of Aug 29, 2024. Special Authority submission is not required. Thank you.","","true","true","true","Actonel and generics","","","","alenrise","","tablet","","9901-0050","","","<p>Risedronate 5mg and 35mg (non-DR formulation)<span style=""font-size: 14px;""> is a PharmaCare regular benefit as of Aug 29, 2024. Special Authority submission is not required. Thank you.</span></p>","5mg, 35mg","","risedronate"
"00G5W000000MXTvUAO","","","false","false","false","Toctino","","","","alitretinoin","","tablet","","9901-0196","","","<p><span style=""font-size: 14px;"">Approved 24 weeks, with a 28 week dispensing window</span></p>","10mg, 30mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/alitretinoin.pdf","alitretinoin"
"00G5W000000MXTvUAO","","","false","true","true","","","","","alternateCGM","","","","999999","","","<p>This device is not a PharmaCare benefit. Further information can be found at: https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/medical-supplies-coverage/diabetes-supplies</p>","","","other CGM non-benefit"
"00G5W000000MXTvUAO","Approved amifampridine up to a maximum dose of 80 mg daily for 3 months. Renewal must be requested by a neurologist and include the current 3TUG test result and date taken.

Patients between 6 and 17 years of age will be provided coverage of eligible brands of amifampridine with the Health Canada pediatric use indication. Coverage will be provided for all eligible brands of amifampridine and amifampridine phosphate for patients 18 years of age and older.","","false","true","true","Ruzurgi, Firdapse","","","","amifampridine","","","","9901-0423","","","","10 mg","","amifampridine"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Solian","","","","amisulpride100mg","","tablet","","66124256","","","<p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","100 mg tablet","","amisulpride (100mg tablet) (SAP)"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Solian","","","","amisulpride400mg","","tablet","","66124235","","","<p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","400 mg tablet","","amisulpride (400mg tablet) (SAP)"
"00G5W000000MXTxUAO","","","false","false","false","PDP-amlodipine solution","","","","amlodipinesoln","","","","9901-0422","","","","1 mg/mL","","amlodipine solution"
"00G5W000000MiSiUAK","","","false","false","false","Kineret","","","","anakinra","","","","9901-0168","","","","100 mg / 0.67 mL","","anakinra"
"00G5W000000MXTxUAO","","","false","false","false","Kytril and generics","","","","antiemeticgran","","","","9901-0109","","Oncologist (medical), Oncologist (radiation)","","1mg, 1mg/mL injection","","granisetron"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible formulations of ondansetron tablets, liquid, injections and orally dissolvable tablets (e.g. Sandoz Brand ODT, Ondissolve ODF).","","false","false","false","Zofran and generics","","","","antiemeticonda","","tablet","","9901-0003","","Oncologist (medical), Oncologist (radiation)","<p>This approval includes PharmaCare eligible formulations of ondansetron tablets, liquid, injections and orally dissolvable tablets (e.g. Sandoz Brand ODT, Ondissolve ODF).┬á</p>","4mg ODT, 8mg ODT, 4mg, 8mg, 4mg/mL solution, 2mg/mL injection","","ondansetron"
"00G5W000000MXTvUAO","","","false","false","false","Loprox","","","","antifungalciclo","","cream","","9901-0049","","","","1% topical","","ciclopirox"
"00G5W000000MXTvUAO","","","false","false","false","Locacorten","","","","antifungalclio","","cream","","9901-0181","","","","3% topical","","clioquinol"
"00G5W000000MXTvUAO","","","false","false","false","Canesten and generics","","","","antifungalclot","","cream","","9901-0134","","","","1% topical","","clotrimazole"
"00G5W000000MXTvUAO","","","false","false","false","Nizoral, Ketoderm cream","","","","antifungalketo","","cream","","9901-0172","","","","2% cream","","ketoconazole topical"
"00G5W000000MXTvUAO","","","false","false","false","Micatin, Monistat","","","","antifungalmico","","Injectable","","9901-0180","","","","2% topical","","miconazole"
"00G5W000000MXTvUAO","Approved for 10mg/mL injection and 10mg, 15mg, 20mg, 25mg and 30 mg sublingual film","","false","false","false","Movapo, Kynmobi","","","","apomorphine","","Injection and sublingual film","","9901-0328","","","","10mg/mL injection, 3ml pre-filled pens, 10mg, 15mg, 20 mg, 25mg and 30 mg sublingual film","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/apomorphine.pdf","apomorphine"
"00G5W000000MXTxUAO","","","false","false","false","Emend","","","","aprepitant","","tablet","","9901-0101","","","Dr. [?] has signed a collaborative prescribing agreement (CPA) for aprepitant.┬á<br>Aprepitant will be treated as a PharmaCare benefit for patients filling a prescription written by this prescriber (subject to patient registration, and deductibles if applicable).┬á<br>With this CPA, Special Authority requests are not required ┬áfor aprepitant used for the prevention of acute and delayed nausea and vomiting due to highly-emetogenic cancer chemotherapy (HEC). Please do not submit aprepitant Special Authority requests for patients that meet the criteria outlined above as this prescriber has a CPA in place for this medication. Thank you.","80mg, 125mg, Tri-Pack","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/aprepitant.pdf","aprepitant"
"00G5W000000MXTvUAO","Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan (8, 16, 32 mg), losartan (25, 50, 100 mg), telmisartan + amlodipine, telmisartan (40, 80 mg), and valsartan (40, 80, 160, 320 mg), and partial coverage of the non-reference ARBs: eprosartan 600mg, irbesartan (75, 150, 300 mg), and olmesartan (20, 40 mg). Approval includes most hydrochlorothiazide combinations as well. www.gov.bc.ca/pharmacare/referencedrugprogram","Patient validated with EMPI Prescriber validated with PNET Diagnosis not equal to &quot;Other&quot;","true","true","true","Atacand/Atacand Plus and generics - reference ARB","","","","ARBcand","","tablet","","9901-0057","","","<p><span style=""font-size: 14px;"">candesartan 4mg</span></p>

<p><span style=""font-size: 14px;"">Not Approved - This strength of candesartan is not eligible for PharmaCare coverage. 8mg tablets can be split in half.</span><br>┬á</p>

<p><span style=""font-size: 11pt;""><span><span style=""font-family: Calibri,sans-serif;"">Approved for full coverage of reference ARBs: candesartan, losartan, telmisartan and valsartan, and partial coverage of the non-reference ARBs: eprosartan, irbesartan, and olmesartan.</span></span></span><br>┬á</p>","8mg, 16mg, 32mg, 16/12.5mg, 32/12.5mg, 32/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","candesartan"
"00G5W000000MXTvUAO","","","false","false","false","Teveten/Teveten Plus - non-reference ARB +/- HCTZ","","","","ARBepro","","tablet","","0024-0057","","","<p>Approved for partial coverage based upon available information. Available PharmaCare records were unable to verify previous fills of candesartan, losartan, telmisartan and valsartan. For further consideration, please specify dates, dosages, and source(s) of medications. If samples were provided, a copy of a consult note documenting trial is required. Thank you.┬á</p>","600mg & 600/12.5mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","eprosartan"
"00G5W000000MXTvUAO","","","false","false","false","Irbesartan/Avalide and generics; non-reference ARB +/- HCTZ","","","","ARBirbe","","tablet","","0024-0057","","","<p><span style=""color: rgb(62, 62, 60);"">Approved for partial coverage based upon available information. Available PharmaCare records were unable to verify previous fills of candesartan, losartan, telmisartan and valsartan. For further consideration, please specify dates, dosages, and source(s) of medications. If samples were provided, a copy of a consult note documenting trial is required. Thank you.┬á</span></p>","75mg, 150mg, 300mg, 150/12.5mg, 300/12.5mg, 300/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","irbesartan"
"00G5W000000MXTvUAO","Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan 8, 16, 32mg ; losartan 25, 50, 100 mg; telmisartan 40, 80 mg; and valsartan 40, 80, 160, and 320 mg; and partial coverage of: eprosartan, irbesartan, and olmesartan","Patient validated with EMPI Prescriber validated with PNET Diagnosis not equal to &quot;Other&quot;","true","true","true","Cozaar/Hyzaar/Hyzaar DS and generics; reference ARB","","","","ARBlosa","","tablet","","9901-0057","","","<span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;"">Approved for full coverage of reference ARBs: candesartan, losartan, telmisartan and valsartan, and partial coverage of the non-reference ARBs: eprosartan, irbesartan, and olmesartan.</span></span></span>","25mg, 50mg, 100mg, 50/12.5mg, 100/12.5mg, 100/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","losartan"
"00G5W000000MXTvUAO","Approved for full coverage of Pharmacare eligible strengths of reference and non-reference ARBs: candesartan (8, 16, 32 mg), losartan (25, 50, 100 mg), telmisartan (40, 80 mg), telmisartan + amlodipine, valsartan (40, 80, 160, 320 mg), eprosartan 600mg, irbesartan (75, 150, 300 mg), and olmesartan (20, 40 mg). Approval includes most hydrochlorothiazide combinations as well. www.gov.bc.ca/pharmacare/referencedrugprogram","","false","false","false","Olmetec/Olmetec Plus and generics; non-reference ARB +/- HCTZ","","","","ARBolme","","tablet","","0024-0057","","","<p><span style=""color: rgb(62, 62, 60);"">Approved for partial coverage based upon available information. Available PharmaCare records were unable to verify previous fills of candesartan, losartan, telmisartan and valsartan. For further consideration, please specify dates, dosages, and source(s) of medications. If samples were provided, a copy of a consult note documenting trial is required. Thank you.┬á</span></p>","20mg, 40mg, 20/12.5mg, 40/12.5mg, 40/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","olmesartan"
"00G5W000000MXTvUAO","Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan (8, 16, 32 mg), losartan (25, 50, 100 mg), telmisartan + amlodipine, telmisartan (40, 80 mg), and valsartan (40, 80, 160, 320 mg), and partial coverage of the non-reference ARBs: eprosartan 600mg, irbesartan (75, 150, 300 mg), and olmesartan (20, 40 mg). Approval includes most hydrochlorothiazide combinations as well. www.gov.bc.ca/pharmacare/referencedrugprogram","Patient validated with EMPI Prescriber validated with PNET Diagnosis not equal to &quot;Other&quot;","true","true","true","Micardis/Micardis Plus and generics; reference ARB","","","","ARBtelm","","tablet","","9901-0057","","","<p><span style=""font-size: 13px;"">Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan 8, 16, 32mg ; losartan 25, 50, 100 mg; telmisartan 40, 80 mg; and valsartan 40, 80, 160, and 320 mg; and partial coverage of: eprosartan, irbesartan, and olmesartan</span></p>","40mg, 80mg, 80/12.5mg, 80/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","telmisartan"
"00G5W000000MXTvUAO","Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan (8, 16, 32 mg), losartan (25, 50, 100 mg), telmisartan + amlodipine, telmisartan (40, 80 mg), and valsartan (40, 80, 160, 320 mg), and partial coverage of the non-reference ARBs: eprosartan 600mg, irbesartan (75, 150, 300 mg), and olmesartan (20, 40 mg). Approval includes most hydrochlorothiazide combinations as well. www.gov.bc.ca/pharmacare/referencedrugprogram","Patient validated with EMPI Prescriber validated with PNET Diagnosis not equal to &quot;Other&quot;","true","true","true","Diovan/Diovan-HCT and generics; reference ARB","","","","ARBvals","","tablet","","9901-0057","","","<p><span style=""font-size: 14px;"">Approved for full coverage of Pharmacare eligible strengths of reference ARBs: candesartan, losartan, telmisartan and valsartan, and partial coverage of the non-reference ARBs: eprosartan, irbesartan, and olmesartan</span></p>","40mg, 80mg, 160mg, 320mg, 80/12.5mg, 160/12.5mg, 160/25mg, 320/12.5mg, 320/25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","valsartan"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible formulations of risperidone microspheres (Risperdal Consta), paliperidone palmitate (Invega Sustenna/Invega Trinza) and aripiprazole Maintena (Abilify Maintena).","","false","false","false","Abilify Maintena","","","","aripiprazoleINJECTION","","","","9901-0081","","","This approval includes PharmaCare eligible formulations of risperidone microspheres (Risperdal Consta), paliperidone palmitate (Invega Sustenna/Invega Trinza) and aripiprazole Maintena (Abilify Maintena).","300mg, 400mg i.m.","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/aripiprazole%20maintena%20ER%20injection.pdf","aripiprazole injection"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.","","false","false","false","Abilify and generics","","","","aripiprazoleORAL","","tablet","","9901-0225","","","<p>This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.</p>","2mg, 5mg, 10mg, 15mg, 20mg, 30mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/aripiprazole.pdf","aripiprazole"
"00G5W000000MXTxUAO","","","false","false","false","Saphris","","","","asenapine","","tablet","","9901-0224","","","","5mg, 10mg","","asenapine"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors.","","false","true","true","Mepron and generics","","","","atovaquone","","oral liquid","https://pdf.hres.ca/dpd_pm/00035998.PDF","9901-0409","250 mg tablets not available","<p>Non-benefit DIN 2217422 </p>","<p>Up to date-PCP proph.</p><p>1.┬áTrimethoprim/sulfamethoxazole (cannot use in patients with anemia, thrombocytopenic neutropenia)</p><p>2.┬áDapsone--**skip dapsone if pt has blood dyscrasias or has g6pd deficiency -&gt; associated with myelosuppression + hemolytic anemia (cannot use in patients with thrombocytopenic neutropenia) **also cross-rxn risk if allergy to sulfa-jfs</p><p>3.┬áatovaquone</p>","750 mg / 5 mL","","atovaquone"
"00G5W000000MiSiUAK","","","false","false","false","Ridaura","","","","auranofin","","","","9901-0197","","","","3 mg","","auranofin"
"00G5W000000MXTpUAO","","","false","false","false","Avonex","","","","Avonex","","","","9901-0118","","Neurologists specializing in MS whose primary place of practice is in a designated MS clinic.","","30mcg IM","","interferon beta-1A"
"00G5W000000MiSjUAK","","","false","false","false","Cayston","","","","aztreonam","","","","9901-0207","","","","75mg/mL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/aztreonam.pdf","aztreonam"
"00G5W000000MXTvUAO","","","false","false","false","Lioresal intrathecal and generics","","","","baclofen","","","","9901-0070","","","","0.05mg/mL, 2mg/mL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/baclofen%20intrathecal.pdf","baclofen"
"00G5W000000MXTxUAO","Apixaban is a PharmaCare regular benefit as of Jan 5, 2023. Special Authority submission is NOT required. Thank you.","","true","true","true","Eliquis","","","","benefitapix","","tablet","","9901-0233","","","<p>Apixaban is a PharmaCare regular benefit as of Jan 5, 2023. Special Authority<br>submission is not required. Thank you.</p>","2.5mg, 5mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/apixaban%202.5%20mg%205%20mg%20DVT%20PE.pdf","apixaban"
"00G5W000000MXTvUAO","","","true","true","true","Forxiga","","","","benefitdapa","","tablet","","9901-0389","","","<p><strong style=""font-size: 16px;"">Dapagliflozin is a PharmaCare regular benefit as of Jan 5, 2023. Special Authority submission is not required.</strong></p><p><strong style=""font-size: 16px;"">Coverage subject to patient eligibility, and deductibles if applicable. Thank you.<span class=""ql-cursor"">∩╗┐</span></strong></p>","10mg","","dapagliflozin"
"00G5W000000MXTvUAO","This medication is an eligible benefit (Special Authority application is not needed for coverage). This medication is available in formulations that are regular Fair PharmaCare benefits (subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price). Thank you. Please note: For PharmaCare benefit information please visit: https://pharmacareformularysearch.gov.bc.ca","","false","false","false","Arava and generics","","","","benefitleflunomide","","tablet","","9901-0064","","","<p><strong>Leflunomide is a PharmaCare regular benefit as of April 2022. Special Authority submission is not required.</strong></p>

<p><strong>Coverage subject to patient eligibility, and deductibles if applicable. Thank you.</strong></p>","10 mg, 20mg","","leflunomide"
"00G5W000000MXTnUAO","","","false","false","false","Fasenra","","","","benralizumab","","","","9901-0333","","","","30mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/Benra%20mepo%20tech%20sheet.pdf","benralizumab"
"00G5W000000MXTxUAO","","","false","false","false","Tantum and generics","","","","benzydamine","","","","9901-0020","","Oncologists (medical or radiation)","","0.15% solution","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/benzydamine%20rinse.pdf","benzydamine"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. 
For consideration of renewal, please provide details demonstrating benefit including:
1. number of transfusions (units of packed cells) now compared to pre-bevacizumab
2. possible reduction in iron infusions
3. reduction in bleeding episodes, if evident
4. improvement in hemoglobin
5. point at which this medication may be discontinued","","false","true","true","Mvasi","","","","bevacizumab","","vials for IV infusion","https://pdf.hres.ca/dpd_pm/00059685.PDF","9901-0410","","<p>Non-benefit</p>","<p>For further consideration of exceptional coverage for biosimilar bevacizumab please clarify:</p><p>- if patient has alternate coverage available (exceptional coverage not considered if alternate coverage available).</p><p>- details regarding current bleeding status (location, severity, current transfusion need)</p><p>- minimum benefit that would be expected from bevacizumab for continued treatment.┬áPlease clarify measures used (e.g. bleeding episodes, # of transfusions per month and Hb levels?), minimum improvement in these measures and current values for comparison.┬á┬á</p><p>- specific details of benefit seen on bevacizumab if tried</p><p>- details of expected long term treatment plan with bevacizumab; is ongoing treatment expected?┬áAt what point (other than intolerance) would tapering and discontinuation be considered?┬á</p><p>Thank you</p>","100mg vial DIN 2470756 & 400mg vial DIN 2470748","","bevacizumab (biosimilar)"
"00G5W000000MXTuUAO","","","false","false","false","Bimzelx","","","","bimekizumab","","","","9901-0420","","","","160 mg/mL","","bimekizumab"
"0055W000000LhdGQAS","","","false","false","false","","","","","biosimilarpatientlist","","","","999999","","","","","","biosimilar patient list request"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient-specific factors. If renewal is required, please provide details demonstrating benefit and tolerability.","","false","false","false","Biphentin","","","","biphentin","","capsules","https://pdf.hres.ca/dpd_pm/00062808.PDF","9901-0161","","","Formulations eligible for PharmaCare coverage are published on the ADHD form:┬á┬á<a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5472fil.pdf"" target=""_blank"">https://www2.gov.bc.ca/assets/gov/health/forms/5472fil.pdf</a>","10, 15,20, 30, 40, 50 60, 80 mg","","biphasic methylphenidate CR [Biphentin type]"
"00G5W000000MXTvUAO","","","true","true","true","Avodart and generics","","","","BPHDUTA","","tablet","","9901-0217","","","","0.5mg","","dutasteride"
"00G5W000000MXTvUAO","","","true","true","true","Proscar and generics","","","","BPHFINA","","tablet","","9901-0106","","","","5mg","","finasteride"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.","","false","false","false","Rexulti","","","","brex","","tablet","","9901-0225","","","<p>This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.</p>","0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/brexpiprazole.pdf","brexpiprazole"
"00G5W000000MXTvUAO","This approval also includes Trelegy 100 Ellipta (fluticasone furoate-umeclidinium-vilanterol).","","false","false","false","Breztri","","","","breztri","","","","9901-0340","","","<p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">No PFTS:</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">Exceptional approval provided without spirometry/PFTs during COVID-19 impact on non-critical PFTs. Please provide PFT results upon renewal. Thank you.</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">-------</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">Not Approved:</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7);"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""font-size: 10.5pt; color: rgb(158, 162, 255); background-color: white;"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","182mcg/8.2mcg/5.8mcg","","budesonide/glycopyrronium/formoterol"
"00G5W000000MXTxUAO","","","false","false","false","Brivlera and generics","","","","brivaracetam","","tablet","","9901-0306","","<p><span style=""font-size: 14px; color: rgb(23, 43, 77);"">No practitioner exemptions</span></p>","<p>Special Authority requests should include documentation stating which other anti-epileptic drugs have been tried in adequate doses. Two trialed products must be described in the request for coverage in order for coverage to be considered for brivaracetam. Examples of other anti-epileptic drugs include:</p><p>ΓÇó phenytoin (Dilantin┬«)</p><p>ΓÇó levetiracetam (Keppra┬«)</p><p>ΓÇó carbamazepine (Tegretol┬«)</p><p>ΓÇó perampanel (FycompaΓäó)</p><p>ΓÇó gabapentin (Neurontin┬«)</p><p>ΓÇó vigabatrin (Sabril┬«)</p><p>ΓÇó topiramate (Topamax┬«)</p><p>ΓÇó eslicarbazepine acetate (AptiomΓäó)</p><p>ΓÇó lamotrigine (Lamictal┬«)</p><p>ΓÇó valproic acid (Epival┬«)</p>","10mg, 25mg, 50mg, 75mg, 100mg tablets","","brivaracetam"
"00G5W000000MXTvUAO","","","true","true","true","Entocort","","","","budcaps","","capsules","","9901-0171","","","","3mg capsules","","budesonide capsules"
"00G5W000000MXTvUAO","","","false","false","false","Entocort","","","","budenema","","enema","","9901-0201","","","","0.02mg/mL enema","","budesonide enema"
"00G5W000000MiSjUAK","Exceptional coverage provided based on patient specific factors. If renewal is required, please provide details of benefit and tolerability to the medication. Thank you.

If patient has a change in income this may result in a new deductible plan for PharmaCare coverage. When the Special Authority is active, this may present as partial coverage for these non-benefit OAT which would have been previously covered at 100%. Please call the HIBC helpdesk to determine when full coverage can be reinstated. Prescriber information line is 1-866-905-4912 and the Pharmacy information line to HIBC is 1-800-554-0225","","false","true","true","Suboxone Film","","","","BupNalFilm","","","","9901-0374","","","<p><strong>** EXCEPTIONAL PLAN Z FOR OAT</strong></p><p><br></p><p>Also exclude: UI and ____</p><p>Note: ____ = The <strong>active</strong> deductible associated plan (e.g., IA, I2, JK, etc.) - see which one under &quot;Value&quot; in the &quot;Patient Benefits&quot; column</p><p><br></p><p>Example for Excluded Plans</p><p>D, S, P, UI, I2</p><p><br></p><p>** Note, check SA PNP to see which plans were excluded. On Salesforce, it the &quot;submitted payload&quot; will default to D, S, P (and not include UI and ___).</p>","2/0.5mg, 4/1mg, 8/2mg, 12/3mg","","buprenorphine/naloxone film (exceptional)"
"00G5W000000MXTxUAO","","","false","false","false","Sublocade","","","","bupre inj","","injection","","9901-0336","","","","100 mg/0.5 mL, 300 mg/1.5 mL","","buprenorphine injection"
"00G5W000000MiSjUAK","","","false","false","false","Butrans","","","","buprenorphine_patches","","patch","","2341174","","","This medication is not eligible for PharmaCare coverage.","5, 10, 15, 20 mcg patch","","buprenorphine patch"
"00G5W000000MiSjUAK","","","false","false","false","Suboxone Sublingual Tablets","","","","buprenorphine-naloxone_8mg2mg_LCAexcep","","","","9901-0431","","","<p><strong>** This is for requests for Suboxone </strong><strong>(LCA) </strong><strong>type buprenorphine/naloxone (8-2mg, 2-0.5mg) sublingual tablets.</strong></p>

<p>┬á</p>

<p>Plan Z - Exceptional</p>","8-2mg, 2-0.5mg sublingual tablets","","Buprenorphine/Naloxone (8-2mg, 2-0.5mg) SL tablets (LCA, exceptional)"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible formulations of bupropion SR 100 and 150mg, as well as bupropion XL 150mg and 300mg. Please note, Zyban 150mg type bupropion is not eligible for indefinite approval. Thank you.","Patient validated with EMPI
Prescriber validated with PNET
Diagnosis not equal to &quot;Other&quot;","true","true","true","Wellbutrin-type and generics","","","","bupropiondepression","","tablet","","9901-0065","","","","100mg & 150mg SR, 150mg & 300mg XL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/bupropion.pdf","bupropion"
"00G5W000000MiSiUAK","","","false","false","false","Stadol","","","","butorphanol","","","","2242504","","","","10 mg / mL","","butorphanol"
"00G5W000000MiSiUAK","","","false","false","false","Dostinex","","","","cabergoline","","tablet","","9901-0206","","","","0.5 mg","","cabergoline"
"00G5W000000MXTxUAO","","","false","false","false","Xarelto","","","","cad","","tablet","","9901-0334","","","","2.5 mg","","rivaroxaban 2.5 mg"
"00G5W000000MXTvUAO","","","false","false","false","Atacand","","","","candesartan4mg","","tablet","","9901-0202","","","<span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;""><strong><span style="""">Candesartan 4mg- Not Approved</span></strong></span></span></span><br><span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;""><span style="""">This strength of candesartan is not eligible for PharmaCare coverage. </span></span></span></span><br><span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;""><strong><span style="""">Candesartan 8,16,32mg (8mg can be split in half)- <span style=""color: red;"">Approved/ Currently Approved xxxx/xx/xx - indefinite</span></span></strong></span></span></span><br><span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;""><span style="""">Approved for full eligible coverage of reference ARBs: candesartan, losartan, telmisartan and valsartan, and, as of December 1, 2016, will receive partial coverage of the non-reference ARBs: eprosartan, irbesartan, and olmesartan.</span></span></span></span><br>┬á","4 mg","","_candesartan (4 mg) exceptional"
"00G5W000000MXTvUAO","","","true","true","true","Coreg and generics","","","","carv","","tablet","","9901-0004","","","","3.125mg, 6.25mg, 12.5mg, 25mg","","carvedilol"
"00G5W000000MXTvUAO","","","false","false","false","Renedil/Plendil","","","","CCBfelo","","tablet","","0024-0200","","","This approval includes: felodipine 2.5, 5 &amp; 10 mg and nifedipine XL 20, 30, &amp; 60mg.","2.5mg, 5mg, 10mg","","felodipine"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible formulations of felodipine 2.5, 5, 10 mg and nifedipine XL 20, 30, and 60mg. Thank you.","","false","false","false","Adalat XL and generics","","","","CCBnife","","tablet","","0024-0020","","","","20, 30, 60 mg","","nifedipine XL"
"00G5W000000MXTvUAO","Approval includes full coverage of non-reference NSAIDS (diclofenac regular release, diclofenac SR, naproxen EC), celecoxib and meloxicam.  Thank you.","","true","true","true","Celebrex and generics","","","","celecox","","tablet","","0041-0070","","","<p><strong><u>Please note,  coverage is provided if they meet either of the following criteria: </u></strong></p><p><br></p><p>Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, or lupus.</p><p><strong><u>OR</u></strong></p><p>had treatment failure on optimal dosages of or intolerance to, BOTH ibuprofen and naproxen.</p><p><br></p><p><br></p>","100mg, 200mg","","celecoxib"
"00G5W000000MXTiUAO","Approved certolizumab _ mg every _ days.","","false","true","true","Cimzia","","","","certo","","","","9901-0126","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved certolizumab 400 mg at 0, 2 and 4 weeks for new treatment starts.</span></p><p><br></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved for 200 mg every 14 days, or 400 mg every 28 days for patients on maintenance dosing after completion of induction doses.┬á</span></p><p><br></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Please note that claims will be monitored and subject to review.┬áFor changes in dosage regimens, please submit renewal application for review by Committee.┬áThank you.</span></p>","200mg/mL","","certolizumab"
"00G5W000000MiSiUAK","","","false","false","false","Reactine","","","","cetirizine","","tablet","","9901-0309","","","","20 mg","","cetirizine"
"00G4m000000hit0EAA","","","false","true","true","Qulipta","","","","cgrpatog","","","","9901-0475","","","","10 mg, 30 mg, 60 mg","","atogepant"
"00G4m000000hit0EAA","","","false","false","false","Vyepti","","","","cgrpepti","","","","9901-0452","","","","100mg/mL, 300 mg/3 mL","","eptinezumab"
"00G4m000000hit0EAA","Approved for a maximum of 225 mg of fremanezumab once monthly or 675 mg every 3 months.","","false","true","true","Ajovy","https://cadth.ca/sites/default/files/cdr/complete/SR0641%20Ajovy%20-%20CDEC%20Final%20Recommendation%20April%201%2C%202021_For%20Posting.pdf","","","cgrpfrem","","","https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98765","","Requests for fremanezumab must be submitted on the correct form. Form can be found here: https://www2.gov.bc.ca/assets/gov/health/forms/5822fil.pdf","","<p><strong>We can accept: </strong></p>

<p><span style=""color: #172b4d; font-size: 14px;"">amitriptyline 10 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">atenolol 100 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">candesartan 16 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">divalproex sodium 500 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">doxepin 25 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">duloxetine 30 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">flunarizine 10 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">gabapentin 1200 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">lisinopril 20 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">lithium 900 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">methysergide 6 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">metoprolol 100 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">nadolol 80 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">nortriptyline 20 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">pizotifen 1 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">propranolol 80 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">timolol 20 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">topiramate 100 mg/day</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">valproic acid 500 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">venlafaxine 150 mg qd </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">verapamil 240 mg qd</span></p>

<p><span style=""color: #172b4d; font-size: 14px;""> </span></p>

<p><strong>DO NOT accept:</strong><span style=""color: #172b4d; font-size: 14px;""> </span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">Any SSRI</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">ANY Injectable prophylactics (Botox, galcanezumab (Emgality), erenumab (Aimovig), fremanezumab (Ajovy))</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">carbamazepine/oxcarbazepine</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">clonidine</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">desvenlafaxine (no trials)</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">nifedipine</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">Other TCA&#39;s-imipramine/trimipramine/clomipramine</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">Other B-blockers - acebutolol/bisoprolol/pindolol</span></p>

<p><span style=""color: #172b4d; font-size: 14px;"">tizanidine</span></p>","150 mg/ml","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/fremanezumab.pdf","fremanezumab"
"00G4m000000hit0EAA","","","false","true","true","Emgality","","","","cgrpgalc","","","","","","","","120 mg/mL","","galcanezumab"
"00G5W000000MXTvUAO","","","false","false","false","Leukeran","","","","chlorambucil","","","","9901-0214","","Rheumatologists","","2mg","","chlorambucil"
"00G5W000000MXTvUAO","","","false","false","false","generic of Aralen","","","","chloroquine","","tablet","","9901-0215","","Rheumatologists","","250mg","","chloroquine"
"00G5W000000MiSjUAK","Exceptional coverage. If renewal is required please provide specific details demonstrating benefit and tolerability, with details of objective (eg. Current Ca and PTH level) as well as subjective improvement and current prescribed dose.","","false","false","false","Sensipar","","","","cinacalcet","","tablet","https://pdf.hres.ca/dpd_pm/00053588.PDF","9901-0273","","","","30, 60, 90 mg","","cinacalcet"
"00G5W000000MXTxUAO","","","false","false","false","Ciloxan and generics","","","","ciproophthcipr","","eyedrops","","9901-0137","","Opthalmologists","","0.3% ophthalmic drops/ointment","","ciprofloxacin"
"00G5W000000MXTwUAO","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details of benefit and tolerability and copy of SAP authorization.","","false","false","false","Apo-Cisapride","","","","cisapride","","","","9901-0223","","","","10 mg","","cisapride (SAP)"
"00G5W000000MXTpUAO","Approved for 1 course, 6 month pick up window.","","false","true","true","Mavenclad","","","","cladribine","","tablet","https://pdf.hres.ca/dpd_pm/00063165.PDF","9901-0391","","","","10mg","","cladribine"
"00G5W000000MXTxUAO","","","false","false","false","Frisium and generics","","","","clobazam","","tablet","","9901-0071","","","","10mg","","clobazam"
"00G5W000000MXTxUAO","","","true","true","true","Codeine Contin","","","","codeine","","tablet","","9901-0035","","","","50mg, 100mg, 150mg, 200mg","","codeine SR"
"00G5W000000MXTxUAO","","","false","true","true","compounded methadone 10 mg/mL OAT","","","","compoundedMethadone10mgpermLOAT","","compounded liquid","","9901-0325","","","<p><strong>** EXCEPTIONAL PLAN Z FOR OAT</strong></p>

<p>┬á</p>

<p>Also exclude: UI and ____</p>

<p>Note: ____ = The┬á<strong>active</strong>┬ádeductible associated plan (e.g., IA, I2, JK, etc.) - see which one under &quot;Value&quot; in the &quot;Patient Benefits&quot; column</p>

<p>┬á</p>

<p>Example for Excluded Plans</p>

<p>D, S, P, UI, I2</p>

<p>┬á</p>

<p>** Note, check SA PNP to see which plans were excluded. On Salesforce, it the &quot;submitted payload&quot; will default to D, S, P (and not include UI and ___).</p>","10 mg/mL","","compounded methadone 10 mg/mL OAT"
"00G5W000000MXTjUAO","","","false","false","false","","","","","compoundrequest","","","","999999","","","","","","Compound Coverage Request"
"00G5W000000MiSiUAK","","","false","false","false","Copaxone","","","","copaxone","","","","9901-0117","","","<p>Exceptional</p>","20 mg / mL","","glatiramer acetate (Copaxone type)"
"00G5W000000MXTvUAO","","","false","false","false","Tudorza Genuair","","","","COPDaclid","","inhaler","","9901-0164","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","400mcg","","aclidinium"
"00G5W000000MXTvUAO","","","false","false","false","Duaklir Genuair","","","","COPDaclidform","","inhaler","","9901-0342","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","400mcg/12mcg","","aclidinium/formoterol"
"00G5W000000MXTvUAO","","","false","false","false","Advair and generics","","","","COPDflutsalm","","Inhaler","","9901-0063","","Respirologists","<p><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Not Approved:</span></p>

<p><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p>

<p><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p>

<p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"" target=""_blank"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a><br><br>Note: Spiriva Respimat and Incruse Ellipta are now regular PharmaCare benefits; no Special Authority required. Thank you.┬á</p>","100/50mcg, 250/50mcg, 500/50mcg diskus & 125/25mcg, 250/25mcg MDI","","fluticasone/salmeterol for COPD"
"00G5W000000MXTvUAO","This approval also includes Breztri Inhaler (budesonide/glycopyrronium/formoterol).","","false","false","false","Trelegy Ellipta","","","","COPDflutumecvila","","Inhaler","","9901-0340","","Respirologists","<p><span style=""font-size: 16px; color: rgb(8, 7, 7); background-color: white;"">No PFTS:</span></p><p><span style=""font-size: 16px;"">Exceptional approval provided without spirometry/PFTs. Please provide PFT results upon renewal. Thank you. (int)</span></p><p><span style=""font-size: 10.5pt; color: rgb(8, 7, 7); background-color: white;"">-------</span></p><p><span style=""font-size: 16px; color: rgb(8, 7, 7); background-color: white;"">Not Approved:</span></p><p><span style=""font-size: 16px; color: rgb(8, 7, 7); background-color: white;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""font-size: 16px; color: rgb(8, 7, 7); background-color: white;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""color: rgb(158, 162, 255); font-size: 16px; background-color: white;"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p><p><br></p><p>┬á</p>","100/62.5/25mcg","","fluticasone/umeclidinium/vilanterol"
"00G5W000000MXTvUAO","","","false","false","false","Breo Ellipta","","","","COPDflutvila","","Inhaler","","9901-0063","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","100mcg/25mcg","","fluticasone/vilanterol COPD"
"00G5W000000MXTvUAO","","","false","false","false","Seebri Breezhaler","","","","COPDglyc","","Inhaler","","9901-0164","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","50mcg","","glycopyrronium"
"00G5W000000MXTvUAO","","","false","false","false","Onbrez Breezhaler","","","","COPDinda","","Inhaler","","9901-0229","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","75mcg","","indacaterol for COPD"
"00G5W000000MXTvUAO","","","false","false","false","Ultibro Breezhaler","","","","COPDindaglyc","","Inhaler","","9901-0342","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","50mcg/110mcg","","indacaterol/glycopyrronium"
"00G5W000000MXTvUAO","","","false","false","false","Serevent Diskus","","","","COPDsalm","","Inhaler","","9901-0341","","Respirologists &amp; Allergists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","50mcg","","salmeterol for COPD"
"00G5W000000MXTvUAO","","","false","false","false","Spiriva Handihaler","","","","COPDtiop","","Inhaler","","9901-0164","","Respirologists","<p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Not Approved:</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""background-color: white; color: rgb(8, 7, 7); font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" target=""_blank"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","18mcg","","tiotropium (handihaler)"
"00G5W000000MXTvUAO","","","false","false","false","Inspiolto Respimat","","","","COPDtiopolod","","Inhaler","","9901-0342","","Respirologists","<p>Exceptional approval provided without spirometry/PFTs during COVID-19 impact on non-critical PFTs. Please provide PFT results upon renewal. Thank you.<br><br><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Not Approved:</span></p>

<p><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p>

<p><span style=""background-color: white; color: #080707; font-size: 10.5pt;"">Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</span></p>

<p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf"" style=""background-color: white; font-size: 10.5pt; color: rgb(158, 162, 255);"" target=""_blank"">https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</a></p>","2.5mcg/2.5mcg","","tiotropium + olodaterol"
"00G5W000000MXTvUAO","","","false","false","false","Anoro Ellipta","","","","COPDumecvila","","Inhaler","","9901-0342","","Respirologists","<p>Not Approved:</p><p>Does not meet criteria for PharmaCare coverage based on available information.</p><p>Please complete the specific form and resubmit (if criteria for coverage have been met). Thank you.</p><p>https://www2.gov.bc.ca/assets/gov/health/forms/5362fil.pdf</p>","62.5mcg/25mcg","","umeclidinium/vilanterol"
"00G5W000000MXTxUAO","","","false","false","false","Neoral and generics","","","","cyclosporin","","tablet","","9901-0006","","","","10mg, 25mg, 50mg, 100mg, & 100mg/mL","","cyclosporine"
"00G5W000000MiSiUAK","","","false","false","false","generics of Restasis","","","","cyclosporine_eyedrops","","eyedrops","","9901-0324","","","","0.5 mg/ml","","cyclosporine eyedrops"
"00G5W000000MXTxUAO","","","false","false","false","Androcur","","","","cyproinj","","Injectable","","704423","","","<p>If Request detail diagnosis equals &quot;Indication of need to reduce aggressive sexual drive&quot;, approval payload will be plan D/S exempt.┬áIf request does not meet published criteria, payload will have default plans - for exceptional plan G approvals please adjust payload manually before submitting, default behaviour is not to include in plan G coverage for non-criteria approvals. Case status must be set to approved for payload of any kind to generate.</p>","100mg/mL injection","","cyproterone injection"
"00G5W000000MXTxUAO","","","false","false","false","Androcur and generics","","","","cyprooral","","tablet","","9901-0043","","","<p>If Request detail diagnosis equals &quot;Indication of need to reduce aggressive sexual drive&quot;, approval payload will be plan D/S exempt.┬áIf request does not meet published criteria, payload will have default plans - for exceptional plan G approvals please adjust payload manually before submitting, default behaviour is not to include in plan G coverage for non-criteria approvals.┬áCase status must be set to approved for payload of any kind to generate.</p>","50mg","","cyproterone tablets"
"00G5W000000MiSjUAK","","","false","true","true","Cystadrops","","","","cysteamineDrops","","eyedrops","","9901-0402","","","","0.37% eyedrops","","cysteamine eye drops"
"00G5W000000MXTxUAO","","","false","true","true","Fragmin","","","","dalteparin","","Injectable","","9901-0022","","","","2500IU, 5000IU, 7500IU, 10000IU, 12500IU, 15000IU, 18000IU syringe, 10000IU amp, 25000IU vial","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/LMWH%20Dalteparin%20Tinzaparin%20for%20cancer%20VTE%20tx.pdf","dalteparin"
"00G5W000000MiSiUAK","","","false","false","false","Enablex","","","","darifenacin","","tablet","","9901-0343","","","","7.5 mg, 15 mg","","darifenacin"
"00G5W000000MXTxUAO","","","false","false","false","Ferriprox","","","","deferprox","","tablet","","9901-0275","","","","1000mg tablet, 100mg/mL solution","","deferiprone"
"00G5W000000MXTxUAO","","","false","false","false","Exjade, Jadenu","","","","defersirox","","tablet","","9901-0102","","","","125mg, 250mg, 500mg and type J┬á90 mg, 180 mg, 360 mg","","deferasirox"
"00G5W000000MXTwUAO","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details of benefit and tolerability and copy of SAP authorization.","","false","false","false","Decort, Dezacor","","","","deflazacort","","","","66123999","","","<p>-Need diagnosis of Duchenne Muscular Dystrophy (DMD)</p><p>-Must be from a neurologist, orthopedic surgeon or pediatrician or a consult letter from a specialist must be attached.</p><p>-Must have copy of the current Health Canada SAP approval document.┬á</p>","6 mg","","deflazacort (SAP)"
"00G5W000000MXTwUAO","","","false","false","false","DEKAs essential capsules","","","","DEKAs_capsules","","","","66127282","","","","","","DEKAs capsules (SAP)"
"00G5W000000MXTvUAO","","","false","false","false","Jubbonti","","","","denobiosim60","","","","9901-0469","","","","60 mg/mL","","denosumab 60mg/mL (biosimilar)"
"00G5W000000MXTvUAO","","","false","false","false","Aclasta","","","","denosacla","","","","9901-0195","","","","5mg/100mL","","zoledronic acid 5mg/100mL"
"00G5W000000MXTvUAO","","","false","false","false","Prolia","","","","denosprol","","Injectable","","9901-0173","","","","60mg/mL","","denosumab 60mg/mL (Prolia)"
"00G5W000000MXTxUAO","","","false","false","false","Pulmozyme","","","","deoxyribonuclease","","","","2046733","","","","1 mg / mL┬á┬á","","dornase alfa deoxyribonuclease┬á┬á"
"00G5W000000MXTvUAO","","","false","false","false","DDAVP and generics","","","","desmopressin","","tablet","","9901-0082","","","","0.1, 0.2 mg tablet","","desmopressin"
"00G5W000000MXTxUAO","Exceptional coverage renewed for one year. For future renewals, please continue to provide details demonstrating continued benefit and tolerability, with details of objective as well as subjective improvement and current prescribed dose. Thank you.","","false","false","false","Pristiq","","","","desvenlafaxine","","tablet","","9901-0226","","","","50, 100 mg","","desvenlafaxine"
"00G5W000000MXTvUAO","If using a CGM, patients may occasionally need blood glucose test strips (for example, if CGM displays an error code or if symptoms donΓÇÖt match CGM readings). CGM users are covered for 200 blood glucose test strips per year.","","true","true","true","Dexcom G6 and G7 Continuous Glucose Monitoring System","","","","DexcomCGM","","","","9901-0376","","","<p>For kids with the check box confirmed:</p>

<p>┬á</p>

<p>This approval also includes approval for no limit Blood Glucose Test Strips. Pharmacies may contact HIBC for correct PINs for billing.</p>

<p>┬á</p>

<p><strong><u>MIR Wording when submitted on generic form:</u></strong></p>

<p><span style=""color: #3e3e3c; font-family: Arial,sans-serif; font-size: 12pt;"">Please resubmit using the Continuous Glucose Monitoring System (Dexcom G6) Special Authority form. The form can be found at:</span></p>

<p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5817fil.pdf"" style=""font-size: 12pt; font-family: Arial, sans-serif; color: rgb(62, 62, 60);"" target=""_blank"">https://www2.gov.bc.ca/assets/gov/health/forms/5817fil.pdf</a></p>

<p>┬á</p>

<p><span style=""background-color: #ffffff; color: #000000; font-size: 14.6667px;"">∩╗┐To allow coverage for children under NSS for blood glucose test strips during the approval period, please have the dispensing pharmacy bill the unlimited PIN# by replacing the second number of the listed PharmaCare PIN with &quot;9&quot; (e.g., One Touch Verio PIN 44123049, now bill PIN 49123049). Thank you.</span></p>

<p>┬á</p>

<p><strong>Currently Approved for Dexcom G6 </strong></p>

<p>Patients who currently have Special Authority for Dexcom G6 also have Special Authority for Dexcom G7.</p>","","","Dexcom G6 and G7 CGM"
"00G5W000000MXTwUAO","","","false","false","false","Firdapse, Ruzurgi","","","","diaminopryridine","","tablet","","66128121","","","<p>DO NOT approve any new requests for amifampridine (SAP or Canadian Ruzurgi/Firdapse brand) at this time....only do renewals for SAP Jacobus product┬á-┬áJanuary 2021-jfs</p>","10 mg","","diaminopyridine"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Proglycem","","","","diazoxide","","suspension","","66124858","","","<p>SAP</p>","50 mg / mL suspension","","diazoxide 50mg/ml suspension (SAP)"
"00G5W000000MXTvUAO","","","false","false","false","Voltaren and generics","","","","diclo","","tablet","","0041-0050","","","Approval includes full coverage of non-reference NSAIDS (diclofenac regular release, diclofenac SR, naproxen E/SR), celecoxib and meloxicam.","","","diclofenac"
"00G5W000000MXTvUAO","Approval includes oral formulations of diclofenac+misoprostal, diflunisil, flurbiprofen, indomethacin, ketoprofen, ketoprofen ER/SR, nabumetone, piroxicam, sulindac, tenoxicam, and tiaprofenic acid.","","false","false","false","Arthrotec and generics","","","","diclomiso","","tablet","","0041-0080","","","","50mg/200mg, 75mg/200mg","","diclofenac + misoprostol"
"00G5W000000MXTvUAO","","","false","false","false","Visanne","","","","dienogest","","tablet","","9901-0210","","","","2mg","","dienogest"
"00G5W000000MXTpUAO","","","false","false","false","Tecfidera","","","","dimethylfumarate","","tablet","","9901-0239","","","","120mg, 240mg PO twice daily","","dimethyl fumarate"
"00G5W000000MXTwUAO","","","false","false","false","Depakote","","","","divalproex_sprinkle","","tablet","","6612-3136","","","","125 mg","","divalproex sprinkle capsule (SAP)"
"00G5W000000MXTxUAO","","","true","true","true","Xarelto","","","","DOACriva","","tablet","","9901-0199","","","<p>DVT/PE:</p>

<p><span style=""font-family: Arial,sans-serif;"">Exceptional indefinite coverage provided at this time due to ongoing COVID-19 impact on INR testing and accessibility to medical services.</span></p>

<p>AFIB:</p>

<p><span style=""font-family: Arial,sans-serif;"">Exceptional coverage provided at this time due to ongoing COVID-19 impact on INR testing and accessibility to medical services.<br><br>Form:<br>https://www2.gov.bc.ca/assets/gov/health/forms/5391fil.pdf</span></p>","","","rivaroxaban 15 mg, 20 mg"
"00G5W000000MXTvUAO","","","false","false","false","Cosopt PF","","","","dorzolamide","","eyedrops","","9901-0191","","","","2%-0.5%","","dorzolamide + timolol preservative free"
"00G5W000000MXTvUAO","Approved for PharmaCare eligible formulations of linagliptin and saxagliptin.

As per empagliflozin/semaglutide criteria, coverage will be provided for either empagliflozin/semaglutide or a DPP-4 inhibitor. With DPP-4 inhibitor approval, any coverage of empagliflozin or semaglutide will be terminated.","","false","true","true","Trajenta/Jentadueto","","","","DPP4lina","","tablet","","9901-0073","","","<p><span style=""font-size: 14px;"">Approved for PharmaCare eligible formulations of linagliptin and saxagliptin.</span></p>

<p><span style=""font-size: 14px;"">As per empagliflozin/semaglutide criteria, coverage will be provided for either empagliflozin/semaglutide or a</span></p>

<p><span style=""font-size: 14px;"">DPP-4 inhibitor. With DPP-4 inhibitor approval, any coverage of empagliflozin or semaglutide will be terminated.</span></p>","5mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/linagliptin%20saxagiptin.pdf","linagliptin with or without metformin"
"00G5W000000MXTvUAO","Approved for PharmaCare eligible formulations of linagliptin and saxagliptin.

As per empagliflozin/semaglutide criteria, coverage will be provided for either empagliflozin/semaglutide or a DPP-4 inhibitor. With DPP-4 inhibitor approval, any coverage of empagliflozin or semaglutide will be terminated.","","false","true","true","Onglyza/Komboglyze","","","","DPP4saxa","","tablet","","9901-0073","","","","2.5mg, 5mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/linagliptin%20saxagiptin.pdf","saxagliptin with or without metformin"
"00G5W000000MXTxUAO","","","false","false","false","Multaq","","","","dronedarone","","tablet","","9901-0145","","","","400mg","","dronedarone"
"00G5W000000MXTxUAO","Special Authority coverage has been provided up to a maximum dose of 60mg/day. Thank you.","","false","false","false","generics only","","","","duloxetine","","tablet","","9901-0185","","","","30mg, 60mg","","duloxetine"
"00G5W000000MXTxUAO","","","false","false","false","Duodopa","","","","duodopa","","","","9901-0330","","","","5-20mg/mL","","Carbidopa-Levodopa Gel"
"00G5W000000MXTnUAO","","","false","false","false","Dupixent","","","","dupilumab","","Injectable","","9901-0432","","","<p>** Committee Drug **</p><p>Please send to the IPF/benra/mepo queue. </p>","200mg/1.14ml, 300mg/2ml","","dupilumab"
"00G5W000000MiSjUAK","","","false","false","false","Radicava","","","","edaravone","","","","9901-0351","","","","30mg/100mL (IV solution), 105mg/5mL (oral suspension)","","edaravone"
"00G5W000000MiSjUAK","","","false","false","false","Lixiana","","","","edoxaban","","tablet","","9901-0318","","","","15mg, 30mg, 60mg","","edoxaban"
"00G5W000000MiSiUAK","","","false","false","false","Relpax","","","","eletriptan","","tablet","","9901-0232","","","","20, 40 mg","","eletriptan"
"00G5W000000MiSjUAK","","","false","false","false","Revolade","","","","eltrombopag","","","","9901-0272","","","","25, 50 mg","","eltrombopag"
"00G5W000000MXTiUAO","","","false","false","false","Enbrel","","","","enbrel","","","","9901-0075","","","","25mg/vial, 50mg/mL","","etanercept (Enbrel)"
"00G5W000000MXTxUAO","","","false","true","true","enoxaparin biosimilars","","","","enoxaparin","","","","9901-0068","","","","30mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg, 300mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/LMWH%20Dalteparin%20Enoxaparin%20Nadroparin%20Tinzaparin.pdf","enoxaparin biosimilars"
"00G5W000000MXTvUAO","","","false","false","false","Comtan, Stalevo and generics","","","","entacapone","","tablet","","9901-0097","","","","200mg and 50mg, 100mg, 150mg","","entacapone"
"00G5W000000MXTlUAO","","","false","false","false","Baraclude and generics","","","","entecavir","","tablet","","9901-0089","","","","0.5mg tablet","","entecavir"
"00G5W000000MXTxUAO","","","false","false","false","Entresto","","","","Entresto","","tablet","","9901-0289","","","","24mg/26mg, 49mg/51mg, 97mg/103mg","","sacubitril/valsartan"
"00G5W000000MXTlUAO","","","false","false","false","Epclusa","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-sofosbuvir-velpatasvir-voxilaprevir","","epclusa","","","","9901-0279","","","","100 mg/400 mg","","velpatasvir/sofosbuvir"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors.","","false","false","false","Inspra","https://www.cadth.ca/media/cdr/complete/cdr_complete_SR0342_Inspra_Apr-28_14.pdf","","","eplerenone","https://fmdb.hlth.gov.bc.ca/AttachmentRetrievalServlet?sub=7102","tablet","https://pdf.hres.ca/dpd_pm/00056405.PDF","9901-0263","","","<p>Can approve INDEF. for heart failure (both initial and renewals).</p><p>IF for some other less common indication where we have rarely approved (e.g. hypertension) stick with 1 year initial approval, possible indef. renewal. jrg</p>","25, 50 mg","","eplerenone"
"00G5W000000MXTtUAO","","","false","false","false","Flolan and Caripul","","","","epoprostenol","","","","9901-0114","","Designated specialist physicians experienced in the diagnosis and treatment of PAH","","0.5mg, 1.5mg","","epoprostenol"
"00G5W000000MXTxUAO","","","false","false","false","Aptiom","","","","eslicarbazepine","","tablet","","9901-0257","","","","200mg, 400mg, 600mg, 800mg","","eslicarbazepine"
"00G5W000000MXTvUAO","","","false","false","false","Estraderm, Estradot, Oesclim, Climara, Vivelle, Estalis, Estrogel, Divigel, and generics","","","","estraderm","","patch/gel","","9901-0055","","","","","","estradiol patches and gel"
"00G5W000000MiSiUAK","","","false","false","false","Vagifem 10","","","","estradiol_tabs","","tablet","","2325462","","","","10 mcg vaginal tablet","","estradiol vaginal tablets"
"00G5W000000MXTiUAO","Approved biosimilar etanercept 50 mg _ weekly","","false","true","true","Erelzi/Brenzys/Rymti","","","","etanbiosim","","","","9901-0286","","Pediatric rheumatologists for pediatric patients diagnosed with rheumatoid arthritis","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Please note that claims will be monitored and subject to review. For changes in dosage regimens, please submit renewal application for review by Committee. Thank you.</span></p>","50mg/mL, 25mg/0.5mL (Erelzi only)","","etanercept (biosimilars)"
"0055W000000LTcsQAG","","","false","false","false","Repatha","","","","evo","","","","","","","","120mg/mL, 140mg/mL","","evolocumab"
"00G5W000000MXTvUAO","","","false","false","false","Ezetrol and generics","","","","ezetimibe","","tablet","","9901-0243","","","","10mg","","ezetimibe"
"00G5W000000MXTvUAO","Please be advised, the FDA added a Boxed warning for increased risk of death with Uloric (febuxostat) on Feb 21, 2019. For more information, please visit: https://www.fda.gov/Drugs/DrugSafety/ucm631182.htm","","false","false","false","Uloric","","","","febuxostat","","tablet","","9901-0174","","","Please be advised, the FDA added a Boxed warning for increased risk of death with Uloric (febuxostat) on Feb 21, 2019. For more information, please visit: https://www.fda.gov/Drugs/DrugSafety/ucm631182.htm","80mg","","febuxostat"
"00G5W000000MXTxUAO","","","false","true","true","Duragesic and generics","","","","fent patch","","patch","","9901-0008","","Oncologist (medical),  Oncologist (radiation), Haematologist","","12mcg, 25mcg, 50mcg, 75mcg, 100mcg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/_layouts/15/DocIdRedir.aspx?ID=F2RWFFZUCM2Q-797944229-1546","fentanyl patches"
"00G5W000000MXTxUAO","","","false","true","true","Fentora","","","","fent tabs","","buccal tablets","","9901-0378","","","","100mcg, 200mcg, 400mcg, 600mcg, 800mcg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/_layouts/15/DocIdRedir.aspx?ID=F2RWFFZUCM2Q-797944229-1545","fentanyl buccal tablets"
"00G5W000000MiSiUAK","","","false","false","false","Toviaz","","NON-Benefit","","fesoterodine","","tablet","","9901-0345","However, solifenacin is available for coverage of OAB; https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/. Thank you","","<p><b>NON BENEFIT</b>┬á</p><p><br></p><p><b>Pharmacist copy-paste</b></p><p>IF patient meets Solifenacin criteria :┬á</p><p><br></p><p>APPROVE┬áSolifenacin 5, 10 mg 9901-0241┬áx indefinite</p><p>As of Aug 4, 2016 eligible generic brands of Solifenacin have become limited coverage benefits, available through Special Authority. This patient is currently approved for indefinite coverage of eligible generic brands of Solifenacin 5mg and 10 mg . Coverage is subject to patient eligibility, deductibles and the lowest cost alternative price, if applicable . Thank you ( initial)┬á</p><p><br></p><p>IF NOT CLEAR Solifenacin criteria is met :┬á</p><p>This medication is not eligible for PharmaCare coverage.</p><p>However, solifenacin is available for coverage of OAB;https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-solifenacin. Thank you. (init)</p>","4 mg, 8 mg","","fesoterodine"
"00G5W000000MXTxUAO","Approved 10 day supply with 5 day window for pick up.","","false","false","false","Dificid","","","","fidaxomicin","","tablet","","9901-0237","","","","200mg","","fidaxomicin"
"00G5W000000MXTxUAO","","","false","false","false","Grastofil, Nivestym","","","","filgrastim","","","","9901-0277","","","","300mcg, 480mcg pre-filled syringes / single use vials","","filgrastim (biosimilar)"
"00G5W000000MXTvUAO","","","false","false","false","Kerendia","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-page-icosapent-75547","","finerenone","","","","9901-0449","","","","10 mg, 20 mg","","finerenone"
"00G5W000000MXTpUAO","","","false","false","false","Gilenya and generics","","","","fingolimod","","","","9901-0228","","","","0.5mg","","fingolimod"
"00G5W000000MXTxUAO","","","false","false","false","Diflucan and generics","","","","fluconsolids","","tablet","","9901-0021","","Physicians specializing in treatment of HIV/AIDS patients","","50mg, 100mg, 150 mg","","fluconazole oral tablets and capsules"
"00G5W000000MiSiUAK","","","false","false","false","Ancoban","","","","flucytosine","","tablet","","6612-8023","","","","500 mg capsules","","flucytosine (SAP)"
"00G5W000000MiSjUAK","","","false","false","false","Arixtra","","","","fondaparinux","","","","9901-0259","","","","2.5, 7.5 mg","","fondaparinux"
"00G5W000000MXTvUAO","If using a Glucose Monitoring System, patients may occasionally need blood glucose test strips (for example, if device displays an error code or if symptoms donΓÇÖt match device readings). FreeStyle Libre users are covered for 200 blood glucose test strips per year.","","true","true","true","FreeStyle Libre 2 Flash Glucose Monitoring System (Abbott)","","","","FreeStyleLibre","","","","9901-0376","","","<p><span style=""font-size: 14px;"">For kids with the check box confirmed:</span></p><p><span style=""font-size: 14px;"">┬á</span></p><p><span style=""font-size: 14px;"">This approval also includes approval for no limit Blood Glucose Test Strips. Pharmacies may contact HIBC for correct PINs for billing.</span></p><p><span style=""font-size: 14px;"">┬á</span></p><p><strong style=""font-size: 14px;""><u>MIR Wording when submitted on generic form:</u></strong></p><p><span style=""font-size: 14px; color: rgb(62, 62, 60);"">Please resubmit using the Glucose Monitoring System (Dexcom G6, FreeStyle Libre 2) Special Authority form. The form can be found at:</span></p><p><a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5817fil.pdf"" target=""_blank"" style=""font-size: 14px; color: rgb(62, 62, 60);"">https://www2.gov.bc.ca/assets/gov/health/forms/5817fil.pdf</a></p><p><span style=""font-size: 14px;"">┬á</span></p><p><span style=""font-size: 14px; color: rgb(0, 0, 0);"">∩╗┐To allow coverage for children under NSS for blood glucose test strips during the approval period, please have the dispensing pharmacy bill the unlimited PIN# by replacing the second number of the listed PharmaCare PIN with &quot;9&quot; (e.g., One Touch Verio PIN 44123049, now bill PIN 49123049). Thank you.</span></p><p><br></p><p><br></p>","","","FreeStyle Libre 2 FGM"
"00G5W000000MXTxUAO","","","false","false","false","Neurontin and generics","","","","gabapentin","","tablet","","9901-0042","","","","100mg, 300mg, 400mg, 600mg, 800mg","","gabapentin"
"00G5W000000MXTpUAO","","","false","false","false","Glatect","","","","glatiramer","","","https://pdf.hres.ca/dpd_pm/00060393.PDF","9901-0313","","<p>CPA MS neurologists</p>","","20 mg / mL","","glatiramer acetate (Glatect)"
"00G5W000000MXTvUAO","","Patient validated with EMPI
Prescriber validated with PNET
Diagnosis not equal to &quot;Other&quot;","true","true","true","Diamicron/Diamicron MR and generics","","","","gliclazide","","tablet","","9901-0019","","<p>None</p>","<p>MIR: Please specify if patient has tried and failed or had an intolerance to one other sulfonylurea (e.g. glyburide) as per attached. Thank you. </p>","80mg regular release and 30mg and 60mg modified release","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/gliclazide.pdf","gliclazide"
"00G5W000000MXTxUAO","Approved for US-Labelled Glucagon while Canadian product is on long term shortage.","","true","true","true","US-Labelled Glucagon Kit 1mg Vial","","","","glucagon","","","","9901-0438","","","<p><strong>∩╗┐<u>Diagnosis has not been specified:</u></strong></p><p>More Information Required ΓÇô Please clarify if diagnosis requiring use is severe hypoglycemia</p><p><br></p><p><strong><u>No med trials rationale noted:</u></strong></p><p>More Information Required ΓÇô Please provide rationale for why the nasal spray dosage form cannot be used in this patient.</p><p><br></p><p><strong><u>Diagnosis has not been specified and no med trials rationale noted:</u></strong></p><p>-<span style=""font-size: 7pt;"">┬á┬á┬á┬á┬á┬á┬á</span>Please clarify if diagnosis requiring use is severe hypoglycemia</p><p>-<span style=""font-size: 7pt;"">┬á┬á┬á┬á┬á┬á┬á</span>Please provide rationale for why the nasal spray dosage form cannot be used in this patient.</p><p><br></p><p><strong><u>No rationale and no diagnosis specified:</u></strong></p><p>Does not meet criteria for coverage based on available information. Thank you.┬á</p>","1mg vial","","glucagon injection"
"00G5W000000MXTiUAO","Approved golimumab 50 mg sc. _","","false","true","true","Simponi","","","","golim","","","","9901-0121","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Golimumab is not available for coverage at the requested dosing rate; if requesting coverage for up to a maximum of 12 doses per year, with additional supply from another source, please give details as applicable. Thank you.┬á</span></p>","50mg s.c.","","golimumab"
"00G5W000000MXTvUAO","","","false","false","false","Zoladex","","","","goserelin","","","","9901-0167","","","","3.6mg, 10.8mg","","goserelin"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Intuniv Xr","","","","guanfacine","","tablet","","9901-0240","","","","","","guanfacine XR"
"00G5W000000MXTvUAO","","","false","false","false","Tagamet and generics","","","","H2Bcime","","tablet","","0036-0100","","","","200mg, 300mg non-reference H2 blocker","","cimetidine"
"00G5W000000MXTvUAO","","","false","false","false","Pepcid and generics","","","","H2Bfamo","","tablet","","0036-0010","","","","20mg, 40mg non-reference H2-blocker","","famotidine"
"00G5W000000MXTvUAO","","","false","false","false","Axid and generics","","","","H2Bniza","","tablet","","0036-0010","","","","150, 300mg non-reference H2-blocker","","nizatidine"
"00G5W000000MXTlUAO","","","false","false","false","Harvoni","","","","harvoni","","","","9901-0247","","","","90 mg/400 mg","","ledipasvir/sofosbuvir"
"00G5W000000MiSiUAK","Exceptional coverage approved due to patient specific factors","","false","true","true","Humalog 100 U/mL","","","","humalog","","","","9901-0386","","","","100 U/mL","","insulin lispro Humalog 100 U/mL"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors","","false","true","true","Humalog Mix","","","","humalogMIX","","","","9901-0387","","","","75/25 and 50/50","","insulin lispro/protamine Humalog MIX"
"00G5W000000MXTiUAO","","","false","false","false","Humira","","","","Humira","","Injectable","","9901-0152","","","","40mg/0.8mL","","adalimumab (Humira)"
"00G5W000000MXTxUAO","","","true","true","true","","","","","hydromorph50inj","","Injectable","","9901-0288","","","","50mg/mL","","hydromorphone injection"
"00G5W000000MXTxUAO","","","true","true","true","Hydromorph Contin and generics","","","","hydromorphSR","","tablet","","9901-0009","","Oncologist (medical), Oncologist (radiation), Haematologist","","3mg, 4mg ,4.5mg, 6mg, 8mg, 9mg, 12mg, 16mg, 18mg, 24mg, 30mg, 32mg","","hydromorphone SR"
"00G5W000000MiSiUAK","","","false","false","false","Dodecavit","","","","hydroxocobalamin","","","","66123904","","","","5 mg / mL","","hydroxocobalamin"
"00G5W000000MXTvUAO","","","false","false","false","Hydrea","","","","hydroxyurea","","tablet","","9901-0138","","","","500mg","","hydroxyurea"
"00G5W000000MXTvUAO","","","true","true","true","Atarax and generics","","","","hydroxyzine","","tablet","","9901-0067","","","","10mg, 25mg, 50mg - Plan G coverage","","hydroxyzine"
"00G5W000000MiSiUAK","","","false","false","false","Hyper-Sal, Nebusal","","","","hypertonic_saline","","","","80029414","","","","saline 7%","","hypertonic saline"
"00G5W000000MXTxUAO","Coverage is provided for the treatment of acute HEA attacks of at least moderate severity. Patients are limited to one pre-filled syringe for self administration. To minimize wastage, patients should not fill an additional dose prior to utilization of the patient's existing on-hand supply.  Maximum PharmaCare coverage of 24 syringes per year.","","false","false","false","Firazyr","","","","icat","","","","9901-0292","","","","30 mg/3 mL","","icatibant"
"00G5W000000MXTvUAO","","","false","true","true","Vascepa","","","","icosapent","","","","9901-0418","","","","1 gram","","Icosapent ethyl"
"00G5W000000MiSiUAK","","","false","false","false","Aldara","","","","imiquimod","","cream","","2239505","","","","5% cream","","imiquimod"
"00G5W000000MXTvUAO","","","false","false","false","Xeomin","","","","incobot","","Injection","","9901-0111","","","<p>For consideration of coverage for incobotulinum toxin, please specify if patientΓÇÖs diagnosis requiring use is cervical dystonia or spasticity of the upper limb post-stroke. Thank you.┬á</p>","50 units/vial, 100 units/vial","","incobotulinum"
"00G5W000000MXTvUAO","","","false","false","false","Lozide and generics","","","","indapamide","","tablet","","9901-0011","","","","1.25mg, 2.5mg","","indapamide"
"00G5W000000MXTiUAO","","","false","true","true","Inflectra/Renflexis (IV), Remsima (SC)","","","","inflix","","","","9901-0261","","Pediatric rheumatologists for pediatric patients diagnosed with rheumatoid arthritis","<p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Please note that claims will be monitored and subject to review. For changes in dosage regimens, please submit renewal application for review by Committee. Thank you.</span></p>","100mg/mL (IV), 120 mg/mL (SC)","","infliximab (biosimilars)"
"00G5W000000MiSjUAK","Exceptional coverage approved due to patient specific factors. 
Approved for CoaguChek INRange and XS meters and strips. Renewal approval includes coverage for strips only.","","false","true","true","CoaguChek","","","","INRtestingdevice","","","","9901-0337","","","","","","INR Testing Device (CoaguChek)"
"00G5W000000MiSiUAK","","","false","false","false","Hypurin Nph Pork","","","","insulin_NPH_pork","","","","2275872","","","","100 U/mL","","insulin NPH pork"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability.","","false","false","false","Entuzity","","","","insulin_R_500","","","","9901-0396","","","","500 U/mL","","Insulin R 500U"
"00G5W000000MXTlUAO","","","false","false","false","Intron-A","","","","interferonA","","","","9901-0018","","","","6m IU/mL, 10m IU/mL, 15m IU/mL, 25m IU/mL, 50m IU/mL and 10m IU/mL vial","","interferon alfa"
"00G5W000000MXTpUAO","","","false","false","false","Betaseron, Extavia","","","","interferonB1B","","","","9901-0110","","Neurologists specializing in MS whose primary place of practice is in a designated MS clinic.","","250mcg SC","","interferon beta-1B"
"00G5W000000MXTxUAO","Approved for one course of treatment of iron isomaltoside up to a maximum cumulative dose of 2000mg (with a 28 day pickup window). Thank you.","","false","true","true","Monoferric","","","","ironisomaltoside","","Injectable","","9901-0379","","","<p><span style=""font-size: 12pt;"">Approved for one course of treatment of iron isomaltoside up to a maximum cumulative dose of 2000mg (with a 28 day pickup window). Thank you.</span></p>","100 mg/mL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/Iron%20sucrose%20iron%20isomaltoside.pdf","iron isomaltoside"
"00G5W000000MXTxUAO","Approved for one course of therapy (up to a maximum 1000mg), with a 28 day window for pick up. Thank you.","","false","true","true","Venofer","","","","ironsucrose","","Injectable","","9901-0380","","","<p><span style=""font-size: 14px;"">One course, with a 28 day window for pick up.</span></p>","20 mg/mL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/Iron%20sucrose%20iron%20isomaltoside.pdf","iron sucrose"
"00G5W000000MiSjUAK","","","false","false","false","Cresemba","","","","isavuconazole","","tablet","","9901-0369","","","","100mg","","isavuconazole"
"00G5W000000MXTvUAO","","","false","false","false","Imdur ER and generics","","","","ismn","","tablet","","0057-0020","","","","60mg","","isosorbide 5 mononitrate SR"
"00G5W000000MXTxUAO","","","false","false","false","Sporonox and generics","","","","itraconazole","","tablet","","9901-0178","","Physicians specializing in treatment of HIV/AIDS patients","","100mg capsules, 10mg/mL solution","","itraconazole"
"00G5W000000MXTvUAO","","","false","false","false","Lancora","","","","ivabradine","","tablet","","9901-0305","","","","5mg, 7.5mg","","ivabradine"
"00G5W000000MXTiUAO","Approved ixekizumab _ mg every _ weeks.","","false","true","true","Taltz","","","","ixekiz","","","","9901-0298","","","<p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">For patients approved for psoriatic arthritis: </span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved for 160 mg ixekizumab for a patientΓÇÖs initial dose, then 80 mg every 4 weeks thereafter (during the approval duration).┬á</span></p><p><br></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">For patients with plaque psoriasis:</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved for 160 mg for a patientΓÇÖs first dose, then 80 mg at weeks 2, 4, 6, 8, 10 and 12 weeks, then approved for an 80 mg dose every 4 weeks for doses thereafter (during the approval duration).┬á</span></p>","80mg/mL","","ixekizumab"
"00G5W000000MiSjUAK","","","false","false","false","Ketalar, Sandoz-Ketamine","","","","ketamine10","","","","9901-0427","","","","10 mg/mL","","ketamine 10 mg/mL injection"
"00G5W000000MiSjUAK","","","false","false","false","Ketalar, Sandoz-Ketamine","","","","ketamine50","","","","9901-0426","","","","50 mg/mL","","ketamine 50 mg/mL injection"
"00G5W000000MXTvUAO","","","false","false","false","Advair and generics","","","","LABAflutsalm","","Inhaler","","9901-0063","","Respirologists","","100/50mcg, 250/50mcg, 500/50mcg diskus & 125/25mcg, 250/25mcg MDI","","fluticasone/salmeterol for asthma"
"00G5W000000MXTvUAO","","","false","false","false","Breo Ellipta","","","","LABAflutvila","","Inhaler","","9901-0339","","Respirologists","","100mcg/25mcg, 200mcg/25mcg","","fluticasone/vilanterol asthma"
"00G5W000000MXTvUAO","","","false","false","false","Oxeze, Foradil","","","","LABAform","","Inhaler","","9901-0349","","Allergists, Respirologists","","6mcg, 12mcg","","formoterol"
"00G5W000000MXTvUAO","","","false","false","false","Symbicort","","","","LABAformbude","","Inhaler","","9901-0339","","Allergists, Respirologists","Please specify if an inhaled corticosteroid has been tried and results. Thank you.","6/100mcg, 6/200mcg","","formoterol/budesonide"
"00G5W000000MXTvUAO","","","false","false","false","Zenhale","","","","LABAformmom","","Inhaler","","9901-0339","","Allergists, Respirologists","","5/100mcg, 5/200mcg","","formoterol/mometasone"
"00G5W000000MXTvUAO","","","false","true","true","Atectura Breezehaler","","","","LABAindamome","","Inhaler","","9901-0339","","Respirologists","","80 mcg, 160 mcg, 320 mcg","","indacaterol/mometasone"
"00G5W000000MXTvUAO","","","false","true","true","Enerzair Breezehaler","","","","LABAindamomeglyco","","Inhaler","","9901-0408","","Respirologists","","160mcg/150mcg/50mcg","","indacaterol/mometasone/glycopyrronium"
"00G5W000000MXTvUAO","","","false","false","false","Serevent Diskus","","","","LABAsalm","","Inhaler","","9901-0063","","Respirologists &amp; Allergists","","50mcg","","salmeterol for asthma"
"00G5W000000MXTxUAO","","","false","false","false","Vimpat and generics","","","","lacolaco","","tablet","","9901-0177","","","","50 mg, 100mg, 150mg, 200mg","","lacosamide"
"00G5W000000MXTvUAO","","","false","false","false","Lactulose","","","","lactulose","","liquid","","9901-0053","","","","10g/15mL","","lactulose"
"00G5W000000MXTxUAO","","","true","true","true","Basaglar, Semglee","","","","LAinsulinbasa","","","","9901-0088","","Endocrinologists","","100IU/mL","","insulin glargine"
"00G5W000000MXTxUAO","","","false","false","false","Levemir","","","","Lainsulindete","","","","9901-0088","","Endocrinologists","","100IU/mL","","insulin detemir"
"00G5W000000MXTlUAO","","","false","false","false","Heptovir and generics","","","","lamivudine","","tablet","","9901-0163","","","","100mg","","lamivudine"
"00G5W000000MiSiUAK","","","false","false","false","Lantus","","","","lantus","","","","9901-0304","","","","100 U/mL","","lantus insulin glargine"
"00G5W000000MXTvUAO","","","false","false","false","Lomotil","","","","LBMdiph","","tablet","","9901-0211","","","","2.5/0.25mg","","diphenoxylate + atropine"
"00G5W000000MiSjUAK","","","false","true","true","Prevymis","","","","letermovir","","tablet","","9901-0371","","","","240, 480 mg","","letermovir"
"00G5W000000MXTvUAO","","","false","true","true","Lupron and generics","","","","leuprolide","","","","9901-0133","","Paediatric endocrinologists","<p><strong style=""font-size: 14px;"">Exceptional Stamps for Pharmacist Use </strong></p><p><span style=""font-size: 14px;"">(Note: the stamps below are not on the technician sheet and are used by pharmacists for potential exceptional requests)</span></p><p><br></p><p><span style=""color: rgb(62, 62, 60); font-size: 14px;"">Does not meet criteria for PharmaCare coverage. For consideration of exceptional coverage, please clarify if leuprolide therapy is intended for pre-operative shrinking of large fibroid(s) in uterus to decrease the risk during surgery. Thank you. Note: long term coverage for this indication is not available. </span></p><p><br></p><p><span style=""font-size: 14px;"">Approved on an exceptional basis for pre-operative shrinking of large fibroid(s) in uterus to decrease the risk during surgery. Long term coverage for this indication is not available. </span><span style=""font-size: 14px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68);""> If renewal required, please provide anticipated date of surgery. </span></p>","5mg/mL, 3.75 mg, 7.5mg, 11.25mg, 22.5 mg","","leuprolide"
"00G5W000000MXTxUAO","Approval has now been granted for PDP-levetiracetam 100mg/mL oral solution (DIN 2490447). 
Please note: Patient also indefinitely approved for levetiracetam tablets.","","false","false","false","PDP-Levetiracetam","https://www.cadth.ca/sites/default/files/cdr/complete/SR0653%20pdp-levETIRAcetam%20-%20CDEC%20Final%20Recommendation%20February%208%2C%202021_For%20Posting.pdf","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-pdp-levetiracetam-oral-solution","","levetiracetam solution","","","https://pdf.hres.ca/dpd_pm/00063948.PDF","9901-0419","","","","100 mg/mL","","levetiracetam solution"
"00G5W000000MXTxUAO","","","true","false","false","Keppra and generics","","","","levetiracetam tablet","","tablet","","9901-0066","","","","250 mg, 500mg, 750mg, 1000mg","","levetiracetam"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. Coverage is provided for levocarnitine 330mg tablets ONLY. 
If renewal required, please provide details demonstrating benefit and tolerability. Thank you","","false","false","false","Carnitor","","","","levocarnitine","","tablet","","9901-0218","","","","330 mg tablets","","levocarnitine"
"00G5W000000MiSjUAK","Exceptional coverage provided based on patient specific factors. 

Approved for 1 course of therapy with a __ day pickup window. Thank you.","","false","false","false","Levaquin","","","","levofloxacin","","tablet","","9901-0069","","","","250, 500, 750 mg","","levofloxacin"
"00G5W000000MXTxUAO","","","false","false","false","Zyvoxam","","","","linezolid","","tablet","","9901-0169","","Infectious Disease Specialists","","600mg tablets","","linezolid"
"00G5W000000MXTxUAO","","","false","false","false","Zyvoxam","","","","linezolidsusp","","liquid","","2243686","","","","100mg/5mL oral suspension","","linezolid suspension"
"00G5W000000MiSiUAK","","","false","false","false","Victoza","","","","liraglutide","","Injectable","","2351064","","","","0.6 mg / 0.1 mL","","liraglutide"
"00G5W000000MiSiUAK","","","false","false","false","Lithmax (Aa Pharma)","","","","lithium_carbonate_SR","","tablet","","2266695","","","","300 mg tablets","","lithium carbonate SR"
"00G5W000000MXTvUAO","","","false","false","false","Immodium","","","","loperamide","","tablet","","9901-0010","","Physicians specializing in treatment of HIV/AIDS patients","","2mg & 1mg/5ml","","loperamide"
"00G5W000000MXTvUAO","","","true","true","true","Lovenox","","","","lovenox","","","","9901-0401","","","","30mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg, 300mg","","enoxaparin LOVENOX BRAND"
"00G5W000000MiSjUAK","Approved for generic lurasidone tablets (20, 40, 60, 80, 120 mg) subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price. Thank you.","","false","false","false","Latuda","https://www.cadth.ca/media/cdr/complete/SR0331_complete_Latuda_Dec-24-13.pdf","","","lurasidone","https://fmdb.hlth.gov.bc.ca/AttachmentRetrievalServlet?sub=7056","tablet","https://pdf.hres.ca/dpd_pm/00055478.PDF","9901-0230","","","","20, 40, 60, 80, 120 mg","","lurasidone"
"00G5W000000MXTxUAO","Approved for 6 months. Please note: PharmaCare provides coverage for a maximum of 1.25 mg/kg (up to 120 mg total dose) every 3 weeks. Use the appropriate combination of strengths of vials to minimize wastage.","","false","true","true","Reblozyl","","","","luspatercept","","","","9901-0421","","","","25 mg vial, 75 mg vial","","luspatercept"
"00G5W000000MiSiUAK","","","false","false","false","Opsumit","","","","macitentan","","tablet","","9901-0383","","","","10 mg","","macitentan"
"00G5W000000MiSiUAK","","","false","false","false","Magnesium","","","","magnesium","","tablet","","9901-0132","","","","50, 100 mg","","magnesium"
"00G5W000000MXTxUAO","This approval includes PharmaCare eligible formulations of risperidone microspheres (Risperdal Consta), paliperidone palmitate (Invega Sustenna/Invega Trinza) and aripiprazole Maintena (Abilify Maintena).","","false","false","false","Invega Sustenna","","","","Maintenapalisust","","Injectable","","9901-0081","","","","50mg/0.5mL, 75mg/0.75mL, 100mg/1mL, 150mg/1.5mL","","paliperidone palmitate"
"00G5W000000MXTxUAO","","","false","false","false","Invega Trinza","","","","Maintenapalitrin","","Injectable","","9901-0081","","","<p>This approval includes PharmaCare eligible formulations of risperidone microspheres (Risperdal Consta), paliperidone palmitate (Invega Sustenna/Invega Trinza) and aripiprazole Maintena (Abilify Maintena).</p>","175mg/0.875mL, 263mg/1.315mL, 350mg/1.75mL, 525mg/2.625mL","","paliperidone palmitate"
"00G5W000000MXTxUAO","","","false","false","false","Risperdal Consta","","","","Maintenarisp","","Injectable","","9901-0081","","","<p>This approval includes PharmaCare eligible formulations of risperidone microspheres (Risperdal Consta), paliperidone palmitate (Invega Sustenna/Invega Trinza) and aripiprazole Maintena (Abilify Maintena).</p>","12.5mg/2mL, 25mg/2mL, 37.5mg/2mL, 50mg/2mL","","risperidone microspheres"
"00G5W000000MXTxUAO","","","false","false","false","Livtencity","","","","maribavir","","","","9901-0466","","","","200 mg","","maribavir"
"00G5W000000MiSjUAK","","","false","true","true","Camzyos","","","","mavacamten","","","","9901-0474","","","","2.5 mg, 5 mg, 10 mg, 15 mg","","mavacamten"
"00G5W000000MXTlUAO","","","false","false","false","Maviret","","","","maviretadult","","","","9901-0315","","","","100/40mg","","glecaprevir/pibrentasvir 100/40mg"
"00G5W000000MXTlUAO","","","false","false","false","Maviret Pediatric","","","","maviretpediatric","","","","9901-0467","","","","50/20mg","","glecaprevir/pibrentasvir 50/20mg"
"00G5W000000MiSjUAK","","","false","false","false","","","","","MaxDayOverride","","","","999999","","","","","","MaxDayOverride"
"00G5W000000MXTvUAO","","","false","false","false","Mobicox and generics","","","","meloxicam","","tablet","","0041-0070","","Rheumatologists","","7.5mg, 15mg","","meloxicam"
"00G5W000000MiSiUAK","","","false","false","false","Alkeran","","","","melphalan","","tablet","","4715","","","","2 mg","","melphalan"
"00G5W000000MiSiUAK","","","false","false","false","Ebixa","","","","memantine","","tablet","","9901-0193","","","","10 mg","","memantine"
"00G5W000000MXTnUAO","Approved for mepolizumab 100mg every 4 weeks. Thank you.","","false","false","false","Nucala","","","","mepolizumab","","","","9901-0311","","","","100mg","","mepolizumab"
"00G5W000000MXTvUAO","","","false","false","false","Purinethol and generics","","","","mercaptopurine","","tablet","","9901-0155","","","","6MP 50mg","","mercaptopurine"
"00G5W000000MiSjUAK","","","false","false","false","methadone injection SAP","","","","methadone_injectable","","Injectable","","6612-4830","","","","1 mg / mL","","methadone injectable"
"00G5W000000MiSjUAK","","","false","false","false","Metadol","","","","methadone_liquid","","liquid","","2247694","","","","1 mg / mL","","methadone 1mg/mL oral solution"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Metadol","","","","methadone_tablets","","tablets","","9901-0252","","","","1, 5, 10, 25 mg","","Methadone tablets"
"00G5W000000MiSjUAK","","","false","false","false","Methadose Dye & Sugar Free Unflavored","","","","methadose_dye_free","","liquid","","9901-0235","","","<p><strong>** EXCEPTIONAL PLAN Z FOR OAT</strong></p>

<p>┬á</p>

<p>Also exclude: UI and ____</p>

<p>Note: ____ = The┬á<strong>active</strong>┬ádeductible associated plan (e.g., IA, I2, JK, etc.) - see which one under &quot;Value&quot; in the &quot;Patient Benefits&quot; column</p>

<p>┬á</p>

<p>Example for Excluded Plans</p>

<p>D, S, P, UI, I2</p>

<p>┬á</p>

<p>** Note, check SA PNP to see which plans were excluded. On Salesforce, it the &quot;submitted payload&quot; will default to D, S, P (and not include UI and ___).</p>","10 mg / mL","","Methadone Dye & Sugar Free Unflavored (excep)"
"00G5W000000MXTvUAO","","","false","false","false","","","","","methotrexatePFsyringe","","Injectable","","9901-0265","","Rheumatologists","","25 mg/mL (available in doses of 7.5 mg, 10 mg, 15 mg, 20 mg and 25 mg)","","methotrexate injectable pre-filled syringes"
"00G5W000000MXTvUAO","","","false","false","false","","","","","methotrexateVial","","Injectable","","9901-0059","","Rheumatologists","","10 mg/mL (available in 2 mL vials) and 25 mg/mL (available in 2 mL and 20 mL vials, with or without preservative)","","methotrexate injectable vials"
"00G5W000000MiSiUAK","","","false","false","false","Celontin (Old Brand Name)┬á","","","","methsuximide","","tablet","","6612-9129","","","","300 mg capsule","","methsuximide"
"00G5W000000MXTxUAO","Exceptional coverage provided based on patient specific factors.","","false","false","false","Versed","","","","midazolam_inj","","Injectable","","9901-0271","","","","5 mg / mL injection","","midazolam (Palliative Benefit)"
"00G5W000000MiSiUAK","","","false","false","false","Impavido","","","","miltefosine","","tablet","","66128802","","","","50 mg capsules","","miltefosine"
"00G5W000000MXTvUAO","PLEASE NOTE: Exceptional coverage of brand Novorapid and Humalog has also been approved for 1 year. Coverage policy may change with advance notice as compatibility data of insulin pumps and biosimilar insulins becomes available.","","false","false","false","MiniMed 670G, 770G or 780G insulin pump by Medtronic","","","","miniMed","","","","9902-0002","","","","","","MiniMed 670G, 770G or 780G Insulin Pump"
"00G5W000000MiSiUAK","","","false","false","false","Myrbetriq","","","","mirabegron","https://fmdb.hlth.gov.bc.ca/AttachmentRetrievalServlet?sub=7162","tablet","","9901-0346","This medication is not eligible for PharmaCare coverage.
However, solifenacin is available for coverage of OAB. Thank you","","","25, 50 mg","","mirabegron"
"00G5W000000MXTmUAO","","","false","false","false","Omvoh","","","","mirikizumab","","","","9901-0472","","","","300mg/15mL, 100mg/1mL","","mirikizumab"
"00G5W000000MXTxUAO","","","false","false","false","Cellcept and generics","","","","mmf","","tablet","","9901-0122","","","","250mg, 500mg","","mycophenolate mofetil"
"00G5W000000MiSjUAK","","","false","false","false","Cellcept","","","","mmf_suspension","","","","9901-0327","","","","200mg/mL","","mycophenolate mofetil 200mg/mL suspension (exceptional)"
"00G5W000000MXTvUAO","","","false","false","false","Alertec and generics","","","","modafinil","","tablet","","9901-0131","","","","100mg","","modafinil"
"00G5W000000MXTvUAO","","","false","false","false","Nasonex","","","","mometNS","","spray","","9901-0187","","","","nasal spray","","mometasone"
"00G5W000000MXTvUAO","","","false","false","false","Monoprost","","","","monoprost","","","","9901-0456","","","","50 mcg/mL","","Monoprost PF eyedrops (exceptional)"
"00G5W000000MiSiUAK","","","false","false","false","Singulair","","","","montelukast","","tablet","","9901-0139","","","For post allogenic stem cell requests:<br><span style=""font-size: 10pt;""><span style=""font-family: Calibri,sans-serif;"">Thank you for the helpful information. Exceptional coverage approved.</span></span><br><span style=""font-size: 10pt;""><span style=""font-family: Calibri,sans-serif;"">For future renewals please provide similar details of ongoing benefit/efficacy seen (e.g., stabilization of FEV1), need for ongoing use, and details of treatment plan at time of renewal.</span></span><br>┬á","4, 5, 10 mg","","montelukast"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Myfortic","","","","mycophenolate_sodium","","tablet","","9901-0258","","","","180, 360 mg","","mycophenolate sodium"
"00G5W000000MXTvUAO","","","false","false","false","Relafen and generics","","","","nabumetone","","tablet","","0041-0080","","Rheumatologists","","500mg, 750mg","","nabumetone"
"00G5W000000MXTxUAO","","","false","true","true","Fraxiparin","","","","nadroparin","","Injectable","","9901-0103","","","","2850IU, 3800IU, 5700IU, 9500IU, 11400IU, 15200IU, 19000IU","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/LMWH%20Dalteparin%20Enoxaparin%20Nadroparin%20Tinzaparin.pdf","nadroparin"
"00G5W000000MiSjUAK","Benefit Medication:
Naltrexone 50mg tablets are a regular Fair PharmaCare benefit (effective April 20, 2023). A Special Authority application is not needed for coverage. Please note, medications are subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price. Thank you.
https://pharmacareformularysearch.gov.bc.ca/faces/Search.xhtml","","false","false","false","Revia","","","","naltrexone","","tablet","","9901-0144","","","<p><strong>Benefit Medication:</strong></p><p>Naltrexone 50mg tablets are a regular Fair PharmaCare benefit (effective April 20, 2023). A Special Authority application is not needed for coverage. Please note, medications are subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price. Thank you.┬á</p><p>https://pharmacareformularysearch.gov.bc.ca/faces/Search.xhtml</p>","50 mg","","naltrexone"
"00G5W000000MXTvUAO","","","false","false","false","Naprosyn and generics","","","","naproEC","","tablet","","0041-0050","","Rheumatologists","","250mg, 375mg, 500 mg","","naproxen EC"
"00G5W000000MXTpUAO","","","false","false","false","Tysabri","","","","natalizumab","","","","9901-0188","","","","300mg IV","","natalizumab"
"00G5W000000MXTvUAO","","","false","false","false","Pulmicort and generics","","","","nebulesbude","","nebules","","9901-0058","","","","nebules 0.25mg/2mL, 0.5mg/2mL, 1mg/2mL","","budesonide nebules"
"00G5W000000MXTvUAO","","","false","false","false","Intal and generics","","","","nebulescrom","","nebules","","9901-0058","","","","nebules 20mg/2mL","","sodium cromoglycate"
"00G5W000000MXTvUAO","","","false","false","false","generics of Atrovent","","","","nebulesipra","","nebules","","9901-0058","","","This approval includes the following nebules: salbutamol, ipratropium, budesonide, cromolyn, and ipratropium + salbutamol combination nebules.┬á","250mg/mL","","ipratropium nebules"
"00G5W000000MXTvUAO","","","false","false","false","Combivent and generics","","","","nebulesiprasalb","","nebules","","9901-0058","","","","2.5mg/0.5mg","","ipratropium + salbutamol nebules"
"00G5W000000MXTvUAO","","","false","false","false","Ventolin and generics","","","","nebulessalb","","nebules","","9901-0058","","","This approval includes the following nebules: salbutamol, ipratropium, budesonide, cromolyn, and ipratropium + salbutamol combination nebules.┬á","nebules 1mg/mL, 2mg/mL, 5mg/mL","","salbutamol nebules"
"00G5W000000MXTxUAO","","","false","false","false","Akynzeo","","","","netupitant","","","","9901-0329","","","","300mg/0.5mg","","netupitant/palonosetron"
"00G5W000000MiSiUAK","","","false","false","false","Neupogen","","","","neupogen","","","","9901-0166","","","","300 mcg / mL vials","","filgrastim (Neupogen type)"
"00G5W000000MiSiUAK","","","false","false","false","Niodan","","","","niacin","","tablet","","9901-0176","","","","500 mg","","niacin ER"
"00G5W000000MiSiUAK","","","false","false","false","Adalat","","","","nifedipine","","tablet","","9901-0221","","","","5, 10 mg","","nifedipine"
"00G5W000000MXTnUAO","","","false","true","true","Ofev","","","","nintedanib","","","","9901-0295","","","","100mg, 150mg","","nintedanib"
"00G5W000000MXTxUAO","","","false","false","false","Orfadin","","","","nitisinone","","","","9901-0358","","","","2mg, 5mg, 10mg, 20mg","","nitisinone"
"00G5W000000MiSiUAK","","","false","false","false","","","","","no_limit_bgts","","test strips","","9901-0250","","","<p>Exceptional coverage approved due to patient specific factors.</p><p>┬á</p><p>Please note, to allow coverage for unlimited blood glucose test strips for the period provided by this approval, please have the dispensing pharmacy bill the unlimited PIN# by replacing the second number of the listed PharmaCare PIN with &quot;9&quot; (e.g., One Touch Verio PIN is 44123049, now bill PIN 49123049).</p><p>┬á</p><p>After the 6 months, patients can use the regular PIN for blood glucose test strips provided on the PharmaCare website:</p><p>https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/pharmacies/product-identification-numbers/diabetes-product-identification-numbers-pins</p><p>┬á</p><p>Coverage for the Dexcom G6 transmitter and sensor has now been terminated. Thank you.</p>","","","no limit blood glucose test strips"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors.","","false","true","true","NovoMix","","","","novomix","","","","9901-0388","","","","30/70","","insulin aspart/protamine NovoMix"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors","","false","true","true","Novorapid 100 U/mL","","","","novorapid","","","","9901-0385","","","","100 U/mL","","insulin aspart Novorapid 100 U/mL"
"00G5W000000MXTvUAO","","","true","true","true","Nicorette / Nicoderm","","","","NRT","","Nicotine patches, gum, lozenges","","9901-0146","","","Patient and Pharmacist must sign smoking cessation document at each fill.┬á<br>Coverage is not provided for a greater than 12 weeks supply per calendar year (not eligible or approved for more than a 12 week supply total per calendar year).┬á<br>---<br>BC Smoking Cessation program provides 12 weeks coverage of a smoking cessation product in a calendar year. This patient has already received maximum coverage for this calendar year.┬á<br>Patient will qualify for 12 weeks coverage starting Jan 1 of the next calendar year┬á","7mg, 14mg, 21mg patches,  2mg, 4 mg gum, 2mg, 4 mg lozenges","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/nicotine%20NRT%20exceptional-approvals.pdf","NRT"
"00G5W000000MXTvUAO","","","false","false","false","Dolobid and generics","","","","NSAIDdiflu","","tablet","","0041-0080","","","","250mg, 500mg","","diflunisal"
"00G5W000000MXTvUAO","","","false","false","false","Froben and generics","","","","NSAIDflur","","tablet","","0041-0011","","","","50mg, 100mg","","flurbiprofen"
"00G5W000000MXTvUAO","","","false","false","false","Indocid and generics","","","","NSAIDindo","","tablet","","0041-0080","","","","25mg, 50mg","","indomethacin"
"00G5W000000MXTvUAO","","","false","false","false","Orudis and generics","","","","NSAIDketo","","tablet","","0041-0080","","","","50, 100mg","","ketoprofen"
"00G5W000000MXTvUAO","","","false","false","false","Rhovail and generics","","","","NSAIDketoSR","","tablet","","0041-0080","","","","200mg","","ketoprofen SR"
"00G5W000000MXTlUAO","Please note: As per Product Monograph revision on Sep 16, 2022, obeticholic acid is contraindicated in PBC patients with decompensated cirrhosis, or a prior decompensation event, or with compensated cirrhosis who have evidence of portal hypertension. Please refer to the Product Monograph for obeticholic acid for further details.","","false","false","false","Ocaliva","","","","OBE","","tablet","","9901-0310","","","","5mg, 10mg","","obeticholic acid"
"00G5W000000MXTpUAO","","","false","true","true","Ocrevus","","","","ocrelizumab","","","","9901-0350","","","","300mg/10mL","","ocrelizumab"
"00G5W000000MiSiUAK","","","false","false","false","Sandostatin","","","","octreotide","","","","9901-0170","","","","50, 100, 200, 500 mcg / mL","","octreotide"
"00G5W000000MXTxUAO","","","false","false","false","Ocuflox and generics","","","","ofloxacin","","eyedrops","","9901-0140","","Opthalmologists","","0.3% ophthalmic drops","","ofloxacin ophthalmic drops"
"00G5W000000MXTxUAO","","","false","false","false","Zyprexa and generics","","","","olan","","tablet","","9901-0001","","","<p><span style=""background-color: #ffffff; color: #3e3e3c;"">This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.</span></p>","2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/olanzapine.pdf","olanzapine"
"0055W000000LTcsQAG","Exceptional coverage provided due to patient specific reason(s).

Coverage has been provided up to ______mg every ____ weeks. Billing above this amount to PharmaCare may result in discontinuation of coverage.","","false","true","true","Xolair","https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_SR0398_Xolair-CIU_May-11-15.pdf","","","omalizumabPFS","https://fmdb.hlth.gov.bc.ca/AttachmentRetrievalServlet?sub=7336","","https://pdf.hres.ca/dpd_pm/00062845.PDF","","","","<p>Non-benefit (exceptional)</p>

<p><span style=""background-color: #ffffff; color: #172b4d; font-size: 14px;"">PFS RDP 9901 0390 is used for doses not divisible by 150 mg (eg 225 mg, 375 mg dosages) for price and wastage or for latex allergy with vials, but not for patient convenience<br><br>oma initial:<br>Dose - <br># daytime sx: <br># nighttime awakenings: <br># exacerbations requiring hospital/ER<br># exacerbations requiring prednisone<br>prednisone fills:<br>ACQ 5:<br><br><br>oma renewal:<br>Dose - <br># daytime sx: <br># nighttime awakenings: <br># exacerbations requiring hospital/ER<br># exacerbations requiring prednisone<br>prednisone fills:<br>ACQ 5:</span><br> </p>","150 mg/mL (DIN: 2459795) and 75 mg/0.5 PFS (DIN: 2459787)","","omalizumab prefilled syringes"
"0055W000000LTcsQAG","Exceptional coverage provided for omalizumab vials DIN 2260565 (maximum dose of 300 mg every 4 weeks) based on patient specific factors. Billing beyond this amount may be subject to discontinuation of coverage.","","false","true","true","Xolair","https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_SR0398_Xolair-CIU_May-11-15.pdf","","","omalizumabvial","","","https://pdf.hres.ca/dpd_pm/00062845.PDF","","","","<p>Non-benefit (exceptional)</p>

<p><span style=""color: #172b4d; font-size: 14px;"">PFS RDP 9901 0390 is used for doses not divisible by 150 mg (eg 225 mg, 375 mg dosages) for price and wastage or for latex allergy with vials, but not for patient convenience</span></p>","150 mg/mL vial (DIN: 2260565)","","omalizumab"
"00G5W000000MiSiUAK","","","false","false","false","Losec 10Mg","","","","omeprazole10mg","","tablet","","9901-0123","","","","10 mg","","omeprazole 10mg"
"00G5W000000MXTvUAO","PLEASE NOTE: Admelog (insulin lispro) is a regular PharmaCare benefit. Coverage for Novorapid-type insulin aspart will not be provided.","","false","false","false","Omnipod Insulin Management System by Insulet","","","","omnipod","","","","9902-0001","","","","","","Omnipod Insulin Pump"
"00G5W000000MXTvUAO","","","false","false","false","Botox","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-botulinum-type-a-botox","","onabot","","Injectable","","9901-0111","","Limited number of neurologists and ophthalmologists.","<p>Not approved</p><p>Does not seem to meet PharmaCare criteria for coverage. If this request does meet criteria please specify which of the criteria this patient&#39;s diagnosis meets, and provide details to support (i.e. if diagnosis includes focal spasticity clearly write &#39;focal spasticity&#39;). Thank you </p>","50 units/vial, 100 units/vial, 200 units/vial","","onabotulinum"
"00G5W000000MXTxUAO","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","","","","","other","","","","999999","","","<span style=""font-size: 11pt;""><span><span style=""font-family: Calibri,sans-serif;""><span style=""font-size: 12.0pt;""><span><span>Approved for exceptional coverage based on patient specific factors.</span></span></span></span></span></span><br><br>┬á","","","other"
"00G5W000000MXTvUAO","","","false","false","false","","","","","otherInsulinPumpNotApproved","","","","999999","","","","","","other insulin pump"
"00G5W000000MXTwUAO","","","false","false","false","","","","","otherSAP","","","","999999","","","","","","other special access program drug"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Trileptal","","","","oxcarbazepine","","tablets / oral suspension","","9901-0084","","","","150, 300, 600 mg tablets and 60 mg / mL oral suspension","","oxcarbazepine (tablets and oral suspension)"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Oxycontin, Oxyneo","","","","oxycodoneSR","","tablet","","9901-0048","","","","10, 15, 20, 30, 40, 60, 80mg","","oxycodone SR"
"00G5W000000MXTmUAO","","","false","true","true","Zeposia","","","","ozanimod","","","","9901-0448","","","","0.23 mg, 0.46 mg, 0.92 mg","","Ozanimod"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient-specific factors for 1 implant for the affected eye. If renewal is required, minimum interval of 6 months/lifetime maximum of 2 implants per eye, please complete the renewal page and resubmit.","","false","false","false","Ozurdex implant","https://www.cadth.ca/sites/default/files/cdr/clinical/SR0535_Ozurdex%20_CL_Report.pdf","","","ozurdex","","intravitreal implant","https://pdf.hres.ca/dpd_pm/00052815.PDF","9901-0368","","","<p><span style=""font-size: 14px; color: rgb(23, 43, 77);"">Can very exceptionally approve 2 implants per eye (max lifetime) at minimum 6 month intervals if meets initial and renewal criteria. Request must be made by Retinal Specialist (list in MDinfo tab of faxlets page) for the diagnosis of DME.┬á</span></p>","0.7 mg","","dexamethasone 0.7mg ocular implant"
"00G5W000000MXTvUAO","","","false","true","true","Fosamax and generics","","","","Pagetsalen","","tablet","","9901-0099","","","<p>This formulation has been discontinued and is not available. </p><p>Criteria page will be removed from the website. </p>","40mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/alendronate%2040mg.pdf","*discontinued med* alendronate 40 mg"
"00G5W000000MXTvUAO","","","false","false","false","Actonel and generics","","","","Pagetsrise","","tablet","","9901-0108","","","<p>Please note the strength on risedronate requests:</p><ul><li>30mg = for Paget&#39;s disease</li><li>5mg, 35mg = for osteoporosis</li></ul><p><br></p><p>Note, now available at McKesson (Teva Risedronate 30mg - DIN 2298384)</p>","30mg","","risedronate 30mg"
"00G5W000000MXTtUAO","","","false","false","false","Volibris","","","","PAH1","","tablet","","9901-0112","","","","5mg, 10mg","","ambrisentan"
"00G5W000000MXTtUAO","","","false","false","false","Tracleer and generics","","","","PAH2","","","","9901-0113","","Designated specialist physicians experienced in the diagnosis and treatment of PAH","","62.5mg, 125mg","","bosentan"
"00G5W000000MXTtUAO","","","false","false","false","Remodulin","","","","PAH4","","","","9901-0080","","","","1mg/mL, 2.5mg/mL, 5mg/mL, 10mg/mL","","treprostinil"
"00G5W000000MXTtUAO","","","false","false","false","Uptravi","","","","PAH5","","","","9901-0287","","","","200mcg, 400mcg, 800mcg, 1000mcg, 1200mcg, 1400mcg, 1600mcg","","selexipag"
"00G5W000000MXTxUAO","","","false","false","false","Aredia","","","","pamidronate","","tablet","","9901-0124","","","","30mg, 60mg, 90mg","","pamidronate"
"00G5W000000MiSiUAK","","","false","false","false","Pantoloc","","","","pantoprazole20mg","","tablet","","9901-0093","","","","20 mg","","pantoprazole sodium (20mg)"
"00G5W000000MiSiUAK","","","false","false","false","Panto Iv","","","","pantoprazoleIV","","Injectable","","9901-0236","","","","40mg/vial","","pantoprazole IV"
"00G5W000000MiSiUAK","","","false","false","false","","","","","paraldehyde_inj","","Injectable","","6612-4590","","","","","","paraldehyde injection"
"00G5W000000MiSjUAK","","","false","false","false","Somavert","","","","pegvisomant","","tablet","","9901-0284","","","","10, 15, 20, 25, 30 mg","","pegvisomant"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Pentam","","","","pentamidine","","","","9901-0393","","","","300mg vial","","pentamidine"
"00G5W000000MXTvUAO","","","false","false","false","Talwin and generics","","","","pentazocine","","tablet","","9901-0205","","","","50mg","","pentazocine"
"00G5W000000MiSiUAK","","","false","false","false","Peptamen 1.5","","","","peptamen","","liquid","","5512-3108","","","","1.5 Cal/ml","","peptamen"
"00G5W000000MiSiUAK","","","false","false","false","Peptamen Junior Liquid","","","","peptamen_jr_liquid","","liquid","","5512-3351","","","","1.0 Cal/ml","","peptamen Junior Liquid"
"00G5W000000MXTxUAO","","","false","true","true","Fycompa","","","","perampanel","","tablet","","9901-0234","","","","2mg, 4mg, 6mg, 8mg, 10mg 12mg","","perampanel"
"00G5W000000MiSiUAK","","","false","false","false","Salagen","","","","pilocarpine","","tablet","","2216345","","","","5 mg tablet","","pilocarpine"
"00G5W000000MXTvUAO","","","true","true","true","Elidel","","","","pimecro","","cream","","9901-0204","","","","1% topical","","pimecrolimus"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Neurolep","","","","piracetam1200mg","","","","66123084","","","<p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","1200 mg","","piracetam (1200 mg) (SAP)"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Neurolep","","","","piracetam400mg","","","","66123051","","","<p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","400 mg","","piracetam (400 mg) (SAP)"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Neurolep","","","","piracetam800mg","","","","66123052","","","<p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","800 mg","","piracetam (800 mg) (SAP)"
"00G5W000000MXTnUAO","","","false","false","false","Esbriet","","","","pirfenidone","","","","9901-0294","","","","267mg, 801mg","","pirfenidone"
"00G5W000000MXTvUAO","","","false","false","false","Feldene and generics","","","","piroxicam","","tablet","","0041-0080","","Rheumatologists","","10mg, 20 mg caps","","piroxicam"
"00G5W000000MiSjUAK","","","false","false","false","Posanol","","","","posaconazole100mg","","tablet","","9901-0365","","","","100 mg tablets┬á","","posaconazole (100mg tablets)"
"00G5W000000MiSjUAK","","","false","false","false","Posanol","","","","posaconazole200mg","","liquid","","2293404","","","","200 mg / 5mL solution","","posaconazole (200mg/5ml solution)"
"00G5W000000MiSiUAK","","","false","false","false","K-Citra Potassium","","","","potassium_citrate","","tablet","","9901-0142","","","","10 mEq","","potassium citrate ER"
"00G5W000000MiSiUAK","","","false","false","false","K-Phos","","","","potassium_phosphate","","tablet","","6612-4742","","","","500 mg","","potassium phosphate (sodium free)"
"00G5W000000MXTvUAO","","","false","false","false","Mirapex","","","","prami","","tablet","","9901-0060","","","","0.25mg, 1mg, 1.5mg","","pramipexole"
"00G5W000000MXTxUAO","","","false","true","true","Effient, JAMP-Prasugrel","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/special-authority-criteria-prasugrel","","prasugrel","","tablet","","9901-0381","","","","10 mg","","prasugrel"
"00G5W000000MiSjUAK","Exceptional coverage on the no-charge psychiatric medication plan (Plan G) due to patient specific factors. If renewal required, please provide details demonstrating benefit and tolerability. Thank you","","false","true","true","prazosin exceptional Plan G","","","","prazosin","","","","9901-0347","","<p>none</p>","<p><span style=""font-size: 14px;"">For consideration of exceptional full coverage on the no-charge psychiatric medication plan, please specify results of past trials with other full PharmaCare benefit(s) (e.g. clonidine, trazodone, olanzapine, SSRIs, etc.), or rationale to avoid in this patient. Thank you┬á</span></p>","1 mg, 2 mg, 5 mg","","prazosin"
"00G5W000000MXTvUAO","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Thank you.","","false","false","false","Lyrica","","","","pregabalin","","tablet","","9901-0186","","","","25, 50, 75, 150, 225, 300 mg","","pregabalin"
"00G5W000000MiSiUAK","","","false","false","false","Pregestimil","","","","pregestimil","","","","5512-3119","","","","","","pregestimil (for Pediatric Cholestasis)"
"00G5W000000MiSiUAK","","","false","false","false","Prometrium","","","","progesterone","","tablet","","9901-0255","","","","100 mg","","progesterone (micronized)"
"00G5W000000MiSjUAK","","","false","false","false","Hemangiol","","","","propranolol","","liquid","","9901-0316","","","","3.75mg/mL solution","","propranolol 3.75mg/mL solution"
"00G5W000000MXTvUAO","","","false","false","false","","","","","prostaglandin","","Injectable","","9901-0357","","","","","","prostaglandin injection compounds"
"00G5W000000MXTvUAO","Exceptional coverage provided due to patient specific factors.","","false","true","true","Resotran","","","","prucalopride","","tablet","","9901-0370","","","","1 mg, 2 mg","","prucalopride"
"00G5W000000MiSiUAK","","","false","false","false","Quinaglute, Quinidex","","","","quinidine","","tablet","","66127999","","","","200 mg tablet","","quinidine sulfate"
"00G5W000000MXTrUAO","","","false","false","false","Evista and generics","","","","ralox","","tablet","","9901-0098","","","","60mg","","raloxifene"
"00G5W000000MXTxUAO","Reimbursement is only provided for drug prepared by select compounding pharmacies and distributed through Provincial Health Services Authority (PHSA). Please email psp@phsa.ca for details on obtaining drug supply.

Patients who meet coverage criteria will be approved for both aflibercept and ranibizumab. However, only one can be used at a time per affected eye. In cases where patients are using both aflibercept and ranibizumab at the same time for the same affected eye, coverage will be discontinued.","","true","true","true","Lucentis aliquoted (compounded) syringe","","","","ranibizumabCMPD","","","","9901-0451","","<p>None</p>","","0.5 mg/0.05mL","","ranibizumab aliquoted syringe"
"00G5W000000MiSiUAK","","","false","false","false","Azilect","https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Azilect_March-28-07.pdf","","","rasagiline","","tablet","","9901-0285","","","<p>This medication is not eligible for PharmaCare coverage. </p>","1 mg","","rasagiline"
"00G5W000000MXTpUAO","","","false","false","false","Rebif","","","","Rebif","","","","9901-0079","","Neurologists specializing in MS whose primary place of practice is in a designated MS clinic.","","22mcg, 44mcg SC","","interferon beta-1A"
"00G5W000000MiSiUAK","","","false","false","false","Infliximab","","","","remicade","","","","9901-0154","","","","100 mg","","Remicade"
"00G5W000000MiSiUAK","","","false","false","false","Gluconorm","","","","repaglinide","","tablet","","9901-0128","","","","0.5, 1, 2 mg","","repaglinide"
"00G5W000000MXTxUAO","","","false","false","false","Zaxine","","","","rifaximin","","tablet","","9901-0293","","","Rifaximin Renewal (Approval) Stamp:<br><br>Exceptional renewal of coverage provided for 1 year. If renewal is required, please provide:<br>1) Specific details demonstrating benefit and tolerability, including frequency of hospital admission compared to pre-treatment<br>2) Current lactulose dosing regimen. Thank you.<br><br><br>┬á","550mg","","rifaximin"
"00G5W000000MXTxUAO","Exceptional coverage provided due to patient specific factors.","","false","false","false","Riluzole","","","","riluzole","","tablet","https://pdf.hres.ca/dpd_pm/00010806.PDF","9901-0212","Indefinite approval","<p>none</p>","<p>Approved if requested by:</p><p>Dr Hannah Briemberg┬á┬á24385┬á┬á</p><p>Dr Neil Cashman┬á┬á25535</p><p>Dr Charles Krieger┬á12093</p><p>Dr. Christine Stables 26171</p><p>from the ALS Clinic, GF Strong</p><p><br></p><p>Not from ALS Clinic, but neurologists who see ALS patients on a semi-regular basis:</p><p>Dr. John Diggle 25538</p><p>Dr. Caire Hinnell 36320┬á┬á┬á</p><p>Ok to approve from other neurologists</p><p>If diagnosis is missing but is from one of the above physicians - please approve Indefinite</p>","50mg","","riluzole"
"00G5W000000MiSiUAK","","","false","false","false","Adempas","","","","riociguat","","","","9901-0267","","","","0.5, 1, 1.5, 2, 2.5 mg ┬á","","riociguat"
"00G5W000000MXTuUAO","Approved risankizumab 150 mg _","","false","true","true","Skyrizi","","","","risan","","","","9901-0335","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved risankizumab 150 mg every 12 weeks </span></p><p><br></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved risankizumab 150mg at week 0, 4, and 16</span></p>","75mg, 150mg","","risankizumab"
"00G5W000000MXTiUAO","","","false","true","true","Riximyo, Ruxience, Truxima","","","","ritux","","Injectable","","9901-0348","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved 2 courses (one course equals 1000 mg of biosimilar rituximab at 0 and 2 weeks).┬áApproximately 6 months between courses</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">-</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved 2 courses (one course equals a single 500 mg dose of biosimilar rituximab).┬áApproximately 6 months between courses</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">-</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Minimum 24 weeks between courses, 1 year window for dispensing.┬áThere must be an ACR 20% improvement after each course to justify administration of a subsequent course. Thank you. </span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Please note that claims will be monitored and subject to review.┬áFor changes in dosage regimens, please submit renewal application for review by Committee.┬áThank you.</span></p>","10mg/mL","","rituximab (biosimilars)"
"00G5W000000MiSjUAK","","","false","false","false","Xarelto","","","","rivaroxaban_liquid","","","","9901-0407","","","","1mg/mL","","rivaroxaban suspension 1mg/mL (exceptional)"
"00G5W000000MXTvUAO","","","false","true","true","Xarelto","","","","rivaroxaban10mg","","tablet","","9901-0107","","","","10 mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/Rivaroxaban%2010%20mg.pdf","rivaroxaban 10 mg"
"00G5W000000MiSiUAK","","","false","false","false","Exelon Patches","","","","rivastigmine_patches","","patch","","9901-0260","","","","4.6mg, 9.5mg, 13.3mg","","rivastigmine patches"
"00G5W000000MiSiUAK","","","false","false","false","Exelon Oral Solution","","","","rivastigmine_soln","","liquid","","9901-0262","","","","2 mg/ml","","rivastigmine oral solution"
"00G5W000000MiSjUAK","","","false","false","false","NPlate","","","","romiplostim_250mcg","","","","9901-0399","","","","250mcg","","romiplostim 250mcg"
"0055W000000UCp2QAG","","","false","false","false","NPlate","","","","romiplostim_500mcg","","","","9901-0400","","","","500mcg","","romiplostim 500mcg"
"00G5W000000MXTrUAO","","","false","false","false","Evenity","","","","romosozumab","","","","9901-0441","","","","105mg/1.17mL","","romosozumab"
"00G5W000000MXTvUAO","","","false","false","false","Requip and generics","","","","ropinirole","","tablet","","9901-0060","","","","0.25mg, 1mg, 2mg, 5mg","","ropinirole"
"00G5W000000MXTvUAO","","","false","false","false","Neupro","","","","rotig","","patch","","9901-0312","","","","2mg, 4mg, 6mg, 8mg/24 hour patch","","rotigotine"
"00G5W000000MXTxUAO","","","false","false","false","Banzel","","","","rufinamide","","","","9901-0200","","","","100mg, 200mg, 400mg","","rufinamide"
"00G5W000000MiSjUAK","","","false","false","false","Jakavi","","","","ruxolitinib","","","","9901-0442","","","","5mg, 10mg","","ruxolitinib"
"00G5W000000MiSjUAK","","","false","false","false","Kuvan","","","","sapropterin","","100 mg tablet; 100mg, 500mg sachet","","9901-0367","","","","100, 500 mg","","sapropterin"
"00G5W000000MXTiUAO","Approved for sarilumab 200 mg every 14 days.
Alternately, approved for 150 mg dosing every 14 days if a step down to that dose is required.","","false","true","true","Kevzara","","","","sarilumab","","","","9901-0302","","","","150mg, 200mg","","sarilumab"
"00G5W000000MXTpUAO","","","false","false","false","Enspryng","","","","satralizumab","","","","9901-0440","","","","120mg prefilled syringe","","satralizumab 120mg/mL prefilled syringe"
"00G5W000000MXTiUAO","Approved secukinumab _","","false","true","true","Cosentyx","","","","secukinumab","","","","9901-0268","","","","150mg/mL","","secukinumab"
"00G5W000000MXTvUAO","Approved for semaglutide injection (up to 1 mg once weekly dose). As per semaglutide criteria coverage will be provided for either semaglutide or a DPP-4 inhibitor. With a semaglutide approval any coverage of a DPP-4 inhibitor will be terminated.┬á┬áCoverage not provided for semaglutide tablets or the Wegovy brand of semaglutide injection.","","true","false","false","Ozempic","","","","semaglutide","","Injectable","","9901-0360","","","<p><strong style=""font-size: 16px;""><u>N/A wording when dx is OBESITY only (no mention of diabetes)</u></strong></p><p><span style=""font-size: 16px;"">Does not meet criteria for PharmaCare coverage based on available information.</span></p><p><span style=""font-size: 16px;"">PharmaCare criteria for semaglutide┬áavailable at:</span></p><p><span style=""color: rgb(0, 0, 0); font-size: 16px;"">https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-semaglutide</span></p><p><span style=""font-size: 16px;"">┬á</span></p><p><strong style=""font-size: 16px;""><u>No metformin fills + no rationale</u></strong><span style=""font-size: 16px;""> = Not approved</span></p><p><span style=""font-size: 16px;"">Does not meet criteria for coverage based on available information (no record of metformin found in PharmaNet dispensing record)</span></p><p><span style=""font-size: 16px;"">┬á</span></p><p><strong style=""font-size: 16px;""><u>ΓÇ£OtherΓÇ¥ diagnosis, does not specify inadequate glycemic control or type 2 diabetes</u></strong><span style=""font-size: 16px;""> = MIR</span></p><p><span style=""font-size: 16px;"">Please clarify if diagnosis includes type 2 diabetes mellitus.</span></p><p><span style=""font-size: 16px;"">┬á</span></p><p><strong style=""font-size: 16px;""><u>Switching back to recently approved ddp4┬á</u></strong></p><p><span style=""font-size: 16px;"">Thank you for this request; if coverage is reactivated for this medication the recently approved coverage for DPP-4 inhibitor will be discontinued and will not be re-approved. Coverage for this medication was recently discontinued upon DPP-4 inhibitor approval as per semaglutide criteria. Coverage for saxagliptin or linagliptin are not provided if semaglutide is approved. Semaglutide coverage is not provided concurrently with these medications. If you wish for the recent DPP-4 approval to be inactivated, and not reapproved, please make this clarification. Your confirmation regarding this will be appreciated. Thank you.┬á</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>If approved for BOTH semaglutide injection and empagliflozin simultaneously:</u></strong></p><p><span style=""font-size: 16px;"">Approved for semaglutide injection (up to 1 mg once weekly dose), empagliflozin, and combined empagliflozin + metformin. Coverage not provided for semaglutide tablets or the Wegovy brand of semaglutide injection. As per PharmaCare criteria, coverage will be provided for semaglutide/empagliflozin or a DPP-4 inhibitor. With a semaglutide/empagliflozin approval, any coverage of a DPP-4 inhibitor will be terminated.</span></p><p><br></p><p><strong style=""font-size: 16px;""><u>Request for semaglutide for doses greater than 1mg weekly if the patient has existing SA approval for semaglutide:</u></strong></p><p><strong>Not Approved</strong> ΓÇô Semaglutide doses greater than 1mg/weekly</p><p>PharmaCare currently provides Special Authority coverage for semaglutide (Ozempic type) up to 1mg once weekly. Special Authority coverage will not be provided for doses greater than 1mg once weekly.</p><p>┬á</p><p><strong>Currently Approved</strong> ΓÇô PharmaCare eligible semaglutide formulation (e.g. Ozempic) up to 1mg once weekly via the 1 mg/dose delivery device.┬áNot approved for using 2x 0.5 mg doses from the pen delivery device designed to give a 0.5 mg dose, as that costs approximately double the price of a single 1 mg dose from the 1 mg/dose pen.┬á┬á</p><p><br></p><p><strong>Link to updated form:</strong> <a href=""https://www2.gov.bc.ca/assets/gov/health/forms/5826fil.pdf"" target=""_blank"" style=""background-color: rgb(255, 255, 255);"">https://www2.gov.bc.ca/assets/gov/health/forms/5826fil.pdf</a></p>","1.34mg/mL","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/semaglutide%20tech.pdf","semaglutide injection"
"00G5W000000MXTvUAO","Approved for empagliflozin and combined empagliflozin + metformin
As per empagliflozin criteria, coverage will be provided for either empagliflozin or a DPP-4 inhibitor. With an empagliflozin approval, any coverage of a DPP-4 inhibitor will be terminated.

It may be helpful to note that single entity dapagliflozin is now a regular PharmaCare benefit (Special Authority approval is not required for PharmaCare coverage of single entity dapagliflozin).┬á","","true","true","true","Jardiance/Synjardy","","","","SGLT2","","tablet","","9901-0320","","","<p><strong><u>ΓÇ£OtherΓÇ¥ diagnosis, does not specify inadequate glycemic control or type 2 diabetes</u></strong><span style=""font-size: 14px;""> = MIR</span></p>

<p><span style=""font-size: 14px;"">Please clarify if diagnosis includes type 2 diabetes mellitus. </span>It may be helpful to note that single entity dapagliflozin is now a regular PharmaCare benefit (Special Authority approval is not required for PharmaCare coverage of single entity dapagliflozin).┬á</p>

<p><span style=""font-size: 14px;"">┬á</span></p>

<p><strong><u>Switching back to recently approved ddp4┬á</u></strong></p>

<p><span style=""font-size: 14px;"">Thank you for this request; if coverage is reactivated for this medication the recently approved coverage for DPP-4 inhibitor will be discontinued and will not be re-approved. Coverage for this medication was recently discontinued upon DPP-4 inhibitor approval as per empagliflozin criteria. Coverage for saxagliptin or linagliptin are not provided if empagliflozin is approved. Empagliflozin coverage is not provided concurrently with these medications. If you wish for the recent DPP-4 approval to be inactivated, and not reapproved, please make this clarification. Your confirmation regarding this will be appreciated. Thank you.┬á</span></p>

<p>┬á</p>

<p><strong><u>∩╗┐If approved for BOTH semaglutide injection and empagliflozin simultaneously:</u></strong></p>

<p>Approved for semaglutide injection (up to 1 mg once weekly dose), empagliflozin, and combined empagliflozin + metformin. Coverage not provided for semaglutide tablets or the Wegovy brand of semaglutide injection. As per PharmaCare criteria, coverage will be provided for semaglutide/empagliflozin or a DPP-4 inhibitor. With a semaglutide/empagliflozin approval, any coverage of a DPP-4 inhibitor will be terminated.</p>

<p>┬á</p>

<p><strong><u>Link to updated empagliflozin:</u></strong></p>

<p><u>https://www2.gov.bc.ca/assets/gov/health/forms/5826fil.pdf</u></p>","10mg, 25mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/empagliflozin%20tech.pdf","empagliflozin with or without metformin"
"00G5W000000MXTtUAO","","","false","false","false","Viagra and generics","","","","sildenafil","","tablet","","9901-0115","","Designated specialist physicians experienced in the diagnosis and treatment of PAH","","25mg, 50mg, 100mg","","sildenafil"
"00G5W000000MiSiUAK","","","false","false","false","Rapaflo","","","","silodosin","","","","9901-0445","","","","4mg, 8mg","","silodosin"
"00G5W000000MXTpUAO","","","false","true","true","Mayzent","","","","siponimod","","tablet","https://pdf.hres.ca/dpd_pm/00060901.PDF","9901-0392","","","","0.25 mg, 2 mg","","siponimod"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability.","","false","false","false","Rapamune","","","","sirolimus","","tablets, liquid","https://pdf.hres.ca/dpd_pm/00053802.PDF","9901-0397","","","<p>Check for 3rd party coverage. </p>","1mg tablet, 1mg/ml liquid","","sirolimus"
"00G5W000000MiSiUAK","","","false","false","false","Januvia and Janumet","","","","sitagliptin","","tablet","","9901-0242","","","","100mg and 50/500mg, 50/1000mg, 100/1000mg","","sitagliptin and sitagliptin + metformin"
"00G5W000000MiSjUAK","","","false","false","false","Albrioza","","","","sodiumphenylbutyrateurso","","","","9901-0428","","","","","","sodium phenylbutyrate ursodoxicoltaurine"
"00G5W000000MXTvUAO","","","false","false","false","generics of Vesicare","","","","solifen","","tablet","","9901-0241","","","","5mg, 10mg","","solifenacin"
"00G5W000000MXTvUAO","","","false","false","false","Saizen, Genotropin, Humatrope, Nutropin, Omnitrope, Somatropin","","","","somatropin","","","","9901-0076","","","<p><br></p><p><br></p>","","","somatropin"
"00G5W000000MXTlUAO","","","false","false","false","Sovaldi","","","","sovaldi","","","","9901-0248","","","","sofosbuvir 400mg with ribavirin 200mg, 400mg, 600mg","","sofosbuvir"
"00G5W000000MXTvUAO","","","false","false","false","Lescol and generics","","","","statinsfluv","","tablet","","0024-0300","","","<p>This approval includes fluvastatin, lovastatin, pravastatin and simvastatin.</p>","20mg, 40mg, XL 80mg","","fluvastatin"
"00G5W000000MXTvUAO","","","false","false","false","Mevacor and generics","","","","statinslova","","tablet","","0024-0300","","","<p>This approval includes fluvastatin, lovastatin, pravastatin and simvastatin.</p>","20mg, 40mg","","lovastatin"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible formulations of fluvastatin, lovastatin, pravastatin and simvastatin.","","false","false","false","Pravachol and generics","","","","statinsprav","","tablet","","0024-0300","","","<p>This approval includes fluvastatin, lovastatin, pravastatin and simvastatin.</p>","10mg, 20mg, 40mg, 80mg","","pravastatin"
"00G5W000000MXTvUAO","This approval includes fluvastatin, lovastatin, pravastatin and simvastatin.","","false","false","false","Zocor and generics","","","","statinssimv","","tablet","","0024-0300","","","<p>This approval includes fluvastatin, lovastatin, pravastatin and simvastatin.</p>","5mg, 10mg, 20mg, 40mg, 80mg","","simvastatin"
"00G5W000000MXTxUAO","","","false","false","false","Diacomit","","","","stiripen","","","","9901-0231","","","","250mg, 500mg","","stiripentol"
"00G5W000000MiSjUAK","","","false","true","true","Suboxone Sublingual Tablet","","","","Suboxone12-16excep","","","","9901-0425","","","<p><strong>** </strong><strong style=""font-size: 14px; background-color: rgb(255, 255, 255);"">Pharmacist adjudication only</strong></p><p><br></p><p><strong>** EXCEPTIONAL PLAN Z FOR OAT</strong></p><p>┬á</p><ol><li>Pharmacists will adjudicate,┬áplace a time frame and save in SF. <strong>Do not push</strong> to Pharmanet.</li><li>Pharmacist will make an activity note ΓÇ£@ Team leads please exclude P/S/D/UI + {patient specific plan}ΓÇ¥</li><li>Leave the case in your cases queue and it will be removed when completed by team leads┬á</li></ol><p><br></p>","12mg-3mg, 16mg-4mg","","Buprenorphine/Naloxone (12-3mg, 16-4mg) SL tablets (exceptional)"
"00G5W000000MXTvUAO","","","false","false","false","Clinoral and generics","","","","sulindac","","","","0041-0080","","Rheumatologists","","100mg, 200mg","","sulindac"
"00G5W000000MXTwUAO","","","false","false","false","Dogmatil","","","","sulpiride","","","","6612-4056","","Neurologists","","200 mg","","sulpiride (SAP)"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Sultiam, Ospolot","","","","sulthiame200mg","","tablet","","9901-0398","","","<p>PIN 66128248</p><p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","200 mg","","sulthiame 200mg tablet (SAP)"
"00G5W000000MXTwUAO","PharmaCare coverage is subject to Special Access Program Approval from Health Canada.  A copy of the current approval must accompany the request for PharmaCare coverage. Medication must be distributed by a licensed pharmacy for PharmaCare reimbursement.","","false","false","false","Sultiam, Ospolot","","","","sulthiame50mg","","tablet","","9901-0398","","","<p>PIN 66124047</p><p>the assumption is that SAP has determined need however if asking questions use the following:</p><p>1. all other medications tried and response</p><p>2. history of hospitalizations including date and duration of stay</p><p>3. results of trial of amisulpiride if available</p><p>4. details of objective improvement on amisulpiride</p><p>5. other medications currently on</p>","50 mg","","sulthiame 50mg tablet (SAP)"
"00G5W000000MXTvUAO","","","false","false","false","Imitrex and generics","","","","sumatrip","","Injectable","","9901-0189","","","","6mg/0.5mL","","sumatriptan injection"
"00G5W000000MXTxUAO","","","false","false","false","Prograf","","","","tacrolimus_caps","","tablet","","9901-0227","","","","","","tacrolimus capsules"
"00G5W000000MXTxUAO","","","true","true","true","Protopic","","","","tacrotopical","","cream","","9901-0141","","","","ointment","","tacrolimus 0.03%, 0.1% topical"
"00G5W000000MXTtUAO","","","false","false","false","Adcirca and generics","","","","tadalafil","","tablet","","9901-0130","","Designated specialist physicians experienced in the diagnosis and treatment of PAH","","20mg","","tadalafil"
"00G5W000000MXTvUAO","","","false","false","false","Arazlo","","","","tazarotene","","","","9901-0453","","","","0.045%","","tazarotene 0.045% lotion"
"00G5W000000MXTlUAO","","","false","false","false","Viread and generics","","","","tenofovir","","tablet","","9901-0182","","","","300mg disoproxil fumarate","","tenofovir"
"00G5W000000MXTvUAO","","","false","false","false","Mobiflex and generics","","","","tenoxicam","","","","0041-0080","","<table class=""ql-table-blob"" border=""0"" style=""width: 65pt;"" width=""86""><tbody><tr height=""20"" style=""height: 15.0pt;""><td colspan=""1"" rowspan=""1"" height=""20"" width=""86"" style=""height: 15.0pt; width: 65pt;"">Rheumatologists</td></tr></tbody></table><p><br></p>","","300mg disoproxil fumarate","","tenoxicam"
"00G5W000000MXTvUAO","","","false","false","false","Lamisil and generics","","","","terbinafine","","tablet","","9901-0041","","Rheumatologists","","250 mg","","terbinafine"
"00G5W000000MXTpUAO","","","false","false","false","Aubagio","","","","teriflunomide","","tablet","","9901-0246","","<p>Neurologists specializing in MS whose primary place of practice is a designated MS clinic.</p>","","14mg PO once daily","","teriflunomide"
"00G5W000000MXTrUAO","","","false","false","false","Teva-teriparatide, Osnuvo (biosimilar)","","","","teriparatide","","injection","","9901-0382","","","","20 mcg","","teriparatide (biosimilar)"
"00G5W000000MiSiUAK","Exceptional coverage provided due to patient specific factors. If renewal is required, please provide details demonstrating benefit and tolerability, as well as current dose. Please note, medications are subject to patient eligibility, deductibles if applicable, and the Low Cost Alternative price. Approved for fully covered Taro-Testosterone gel packets. This also includes partial coverage of brand Androgel (pump and packets) and Testim.","","false","false","false","Androgel, Testim","","","","testosterone_gel","","Injectable","","9901-0297","","","","1% gel","","testosterone gel"
"00G5W000000MiSiUAK","","","false","false","false","Androderm","","","","testosterone_patches","","gel","","2245972","","","","2.5 mg, 5 mg patches","","testosterone patches"
"00G5W000000MiSiUAK","","","false","false","false","Andriol","","","","testosterone_undecanoate","","Injectable","","9901-0129","","","","40 mg","","testosterone undecanoate"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible injectable formulations of testosterone cypionate 100, 200 mg/mL and testosterone enanthate. Thank you.","","true","true","true","Depo-Testosterone and generics","","","","testosteronecypi","","","","9901-0046","","","","100mg/mL","","testosterone cypionate"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible injectable formulations of testosterone cypionate 100, 200 mg/mL and testosterone enanthate. Thank you.","","true","true","true","Delatestryl and generics","","","","testosteroneenan","","Injectable","","9901-0046","","","","200mg/mL","","testosterone enanthate"
"00G5W000000MXTvUAO","This approval includes PharmaCare eligible injectable formulations of testosterone propionate 100mg/mL, testosterone cypionate 100, 200 mg/mL and testosterone enanthate. Thank you.","","false","true","true","generics","","","","testosteroneprop","","patch","","9901-0046","","","","100mg/mL","","testosterone propionate"
"00G5W000000MXTnUAO","","","false","false","false","Tezspire","","","","tezepelumab","","","","9901-0446","","","","210mg/1.91mL (110mg/mL) pre-filled syringe and pen","","tezepelumab"
"00G5W000000MXTwUAO","","","false","false","false","Mellaril, Mellaril-S","","","","thioridazine100mg","","tablet","","6612-4538","","","","100 mg","","thioridazine HCL 100 mg tablet"
"00G5W000000MXTwUAO","","","false","false","false","Mellaril, Mellaril-S","","","","thioridazine10mg","","Injectable","","6612-4538","","","","10 mg","","thioridazine HCL 10 mg tablet"
"00G5W000000MXTwUAO","","","false","false","false","Mellaril, Mellaril-S","","","","thioridazine25mg","","tablet","","6612-4541","","","","25 mg","","thioridazine HCL 25 mg tablet"
"00G5W000000MXTwUAO","","","false","false","false","Mellaril, Mellaril-S","","","","thioridazine50mg","","tablet","","6612-4547","","","","50 mg","","thioridazine HCL 50 mg tablet"
"00G5W000000MXTvUAO","","","false","false","false","Surgam and generics","","","","tiaprofenic","","tablet","","0041-0080","","","","200mg, 300mg","","tiaprofenic acid"
"00G5W000000MXTxUAO","","","false","true","true","Brilinta","","","","ticag","","tablet","","9901-0209","","Cardiologists","","90mg","","ticagrelor 90mg"
"00G5W000000MXTxUAO","","","false","false","false","generics of Ticlid","","","","ticlo","","tablet","","9901-0032","","","","250mg","","ticlopidine"
"00G5W000000MXTxUAO","","","true","true","true","Innohep","","","","tinzaparin","","Injectable","","9901-0023","","","","2500IU, 3500IU, 4500IU, 8000IU, 10000IU, 12000IU, 14000IU, 16000IU, 18000IU syringe, 10000IU vial","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/LMWH%20Dalteparin%20Tinzaparin%20for%20cancer%20VTE%20tx.pdf","tinzaparin"
"00G5W000000MiSiUAK","","","false","false","false","Thiola","","","","tiopronin","","tablet","","6612-3902","","","","100 mg","","tiopronin tablet"
"00G5W000000MXTvUAO","","","false","false","false","Zanaflex","","","","tizan","","tablet","","9901-0077","","","","4mg","","tizanidine"
"00G5W000000MXTxUAO","","","false","false","false","Tobi Podhaler, Tobi nebules and generics","","","","tobi","","nebules","","9901-0208","","","","28mg, 300mg/mL","","tobramycin"
"00G5W000000MiSjUAK","Exceptional coverage approved for Tobramycin 300 mg/5mL Teva DIN: 2389622","","false","true","true","tobramycin, Teva brand","","","","tobramycin300nebsExceptional","","nebules","","2389622","","","<p><span style=""color: rgb(23, 43, 77); font-size: 14px;"">For ANY indication that does not meet published criteria (treatment of chronic PsA in patients with mod-severe CF and intolerance with inhaled injectable tobramycin) DO NOT approve the non-RDP code. Only approve the LCA 300 mg/5 mL DINs 2389622</span></p><p><span style=""color: rgb(23, 43, 77); font-size: 14px;"">Sandoz D/Cd Oct 2021</span></p>","300 mg / 5 mL","","tobramycin 300 mg/5 mL nebules for exceptional coverage"
"00G5W000000MXTiUAO","","","false","true","true","Actemra","","","","tociliz","","","","9901-0147","","","<p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved tocilizumab 162 mg sc. _</span></p><p><br></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved tocilizumab IV _ mg every _ weeks.</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">?</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Please note that claims will be monitored and subject to review.┬áFor changes in dosage regimens, please submit renewal application for review by Committee.┬áThank you.</span></p>","80mg/4mL, 200mg/10mL, 400mg/20mL IV and 162mg/0.9mL s.c.","","tocilizumab"
"00G5W000000MXTiUAO","Approved tofacitinib __mg daily.","","false","true","true","Xeljanz","","","","tofacitinib","","tablet","","9901-0278","","","","strength dependent on indication","","tofacitinib"
"00G5W000000MiSiUAK","","","false","false","false","Detrol, Detrol La","","","","tolterodine","","tablet","","9901-0165","","","","1 mg, 2 mg, 2 mg LA, 4 mg LA","","tolterodine"
"00G5W000000MXTvUAO","","","false","false","false","Tramacet","https://www.cadth.ca/media/cdr/complete/cdr_complete_Tramacet_May17-07.pdf","","","tramacet","","tablet","","9901-0213","","","<p>This medication is not eligible for PharmaCare coverage. </p>","37.5┬ámg/325┬ámg","","tramadol + acetaminophen combination"
"00G5W000000MXTvUAO","","","false","false","false","Retin-A, Vitamin-A, Stieva-A","","","","tretinoin","","cream","","9901-0083","","","","0.01%,  0.025%, 0.05%, 0.1% topical","","tretinoin"
"00G5W000000MiSjUAK","PharmaCare coverage approved for 1 year.┬á If renewal required please provide current prescribed dose and specific details demonstrating benefit and tolerability. Thank you.","","false","true","true","MAR-trientine, Waymade-trientine","https://www.cadth.ca/sites/default/files/DRR/2021/SR0680%20MAR-Trientine%20-%20CADTH%20Final%20Rec-meta.pdf","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-trientine","No DBC review","trientine","","tablet","https://pdf.hres.ca/dpd_pm/00057903.PDF","9901-0364","","<p>none</p>","","250 mg","","trientine"
"00G5W000000MiSiUAK","","","false","false","false","Trosec","","","","trospium","","","","9901-0344","","","","20 mg","","trospium"
"00G5W000000MXTvUAO","Approved for full coverage of eligible Pharmacare strengths of reference ARBs: candesartan (8, 16, 32 mg), losartan (25, 50, 100 mg), telmisartan + amlodipine, telmisartan (40, 80 mg), and valsartan (40, 80, 160, 320 mg), and partial coverage of the non-reference ARBs: eprosartan 600mg, irbesartan (75, 150, 300 mg), and olmesartan (20, 40 mg). Approval includes most hydrochlorothiazide combinations as well. www.gov.bc.ca/pharmacare/referencedrugprogram","","false","false","false","Twynsta","","","","Twynsta","","tablet","","9901-0057","","","<span style=""font-size: 11pt;""><span style=""""><span style=""font-family: Calibri,sans-serif;"">Approved for full coverage of reference ARBs: candesartan, losartan, telmisartan and valsartan, and partial coverage of the non-reference ARBs: eprosartan, irbesartan, and olmesartan.</span></span></span><br>┬á","40/5mg, 40/10mg, 80/5mg, 80/10mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/arb%20form%20tech%20page%20candesartan%20losartan%20telmisartan%20valsartan%20eprosartan%20olmesartan%20irbesartan.pdf","telmisartan/amlodipine"
"00G5W000000MXTvUAO","","","false","true","true","Actos and generics","","","","TZDpio","","tablet","","9901-0361","","","<p><b><u>Unable to confirm fills wording (delete the med not needed ie met/sulf/insu)</u></b></p><p><br></p><p>Not approved based upon available information. Available PharmaCare records were unable to verify previous fills of metformin/sulfonylurea/Insulin For further consideration, please specify dates, names, dose, and results of trial. If samples were provided, a copy of a consult note documenting trial is required. Thank you.</p>","15mg, 30mg, 45mg","","pioglitazone"
"00G5W000000MXTuUAO","","","false","true","true","Rinvoq","https://www.cadth.ca/sites/default/files/DRR/2022/SR0685-Rinvoq-AD.pdf","","","upadacitinib","https://www.cadth.ca/sites/default/files/DRR/2022/SR0685-Rinvoq-AD.pdf","","https://pdf.hres.ca/dpd_pm/00072861.PDF","9901-0443","","","","15mg, 30mg, 45mg","","upadacitinib"
"00G5W000000MXTuUAO","","","false","true","true","Stelara","","","","uste","","","","9901-0157","","","<p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved ustekinumab 45mg at week 0, 4, and 16</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved ustekinumab 90mg at week 0, 4, and 16</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved ustekinumab 45mg every 12 weeks</span></p><p><span style=""font-family: Calibri, sans-serif; font-size: 11pt;"">Approved ustekinumab 90mg every 12 weeks</span></p>","45mg, 90mg","","ustekinumab (Stelara)"
"00G5W000000MXTmUAO","","","false","true","true","Wezlana,Steqeyma","","","","ustebiosimIVSC","","","","9901-0461","","","","90 mg/mL (syringe)  45 mg/0.5 mL (vial)  130 mg/26 mL (vial)","","ustekinumab IV (biosimilar)"
"00G5W000000MXTuUAO","","","false","true","true","Jamteki, Wezlana,Steqeyma","","","","ustebiosimSC","","","","9901-0460","","","<p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved ustekinumab 45mg at week 0, 4, and 16</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved ustekinumab 90mg at week 0, 4, and 16</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved ustekinumab 45mg every 12 weeks</span></p><p><span style=""font-size: 11pt; font-family: Calibri, sans-serif;"">Approved ustekinumab 90mg every 12 weeks</span></p>","45mg/0.5mL , 90mg/1.0 mL prefilled syringe and (Wezlana,Steqeyma) 45mg/0.5mL) vial","","ustekinumab SC (biosimilar)"
"00G5W000000MXTxUAO","","","false","false","false","Valcyte","","","","valganciclovir","","","","9901-0120","","Specialist physicians with the Leukemia/BMT Program at Vancouver General Hospital.","","450mg, 50mg/mL","","valganciclovir"
"00G5W000000MXTxUAO","","","true","true","true","Vancocin","","","","vancomycin","","tablet","","9901-0104","","","","125mg, 250mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/vancomycin.pdf","vancomycin"
"00G5W000000MXTvUAO","","","false","false","false","Champix","","","","varenicline","","","","9901-0148","","","","0.5 mg, 1mg","","varenicline"
"00G5W000000MXTmUAO","Approved vedolizumab ___ mg every ___ weeks","","false","true","true","Entyvio","","","","vedoIV","","Injectable","","9901-0283","","","<p>Following standard induction of either 300 mg IV at weeks 0, 2, and 6, or 300 mg IV at weeks 0 and 2 with 108 mg SC at weeks 6, 8, 10, and 12</p>","300 mg/vial or 108 mg/0.68 mL","","vedolizumab"
"00G5W000000MXTxUAO","","","false","true","true","Verquvo","","","","vericiquat","","","","9901-0468","","","","2.5mg, 5mg, 10mg","","vericiquat"
"00G5W000000MXTxUAO","","","false","false","false","Vfend and generics","","","","voriconazole","","tablet","","9901-0125","","","","50mg, 200mg tablets; 200mg injection","","voriconazole"
"00G5W000000MiSiUAK","","","false","false","false","Vfend","","","","voriconazole_susp","","liquid","","2279991","","","","200 mg / 5 mL","","voriconazole oral susp"
"00G5W000000MXTxUAO","","","false","false","false","Trintellix","","","","vortioxetine","","tablet","","9901-0264","","","","5mg, 10mg, 20mg","","vortioxetine"
"00G5W000000MXTlUAO","","","false","false","false","Vosevi","","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-sofosbuvir-velpatasvir-voxilaprevir","","vosevi","","","","9901-0300","","","","100 mg/400 mg/100 mg","","velpatasvir/sofosbuvir/voxilaprevir"
"00G5W000000MXTxUAO","","","false","false","false","Vyalev","","","","vyalev","","","","9901-0463","","","","20-5 mg/mL","","foslevodopa/foscarbidopa"
"00G5W000000MiSjUAK","Exceptional coverage provided due to patient specific factors.","","false","false","false","Xgeva","https://www.cadth.ca/media/cdr/complete/cdr_complete_Xgeva_Nov-18-11_e.pdf","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/plan-p-bc-palliative-care-benefits-program/plan-p-formulary#bone-metabolism","","xgeva","","Injectable","https://pdf.hres.ca/dpd_pm/00059342.PDF","2368153","","<p>None</p>","<p>Plan P benefit</p><p>BCCA only provides coverage for denosumab for treatment of non-Metastatic Operable Giant Cell Tumor of the Bone</p><p>BCCA provides coverage of pamidronate for bone mets associated with breast cancer only. jfs</p>","120 mg/0.7 mL format","","denosumab 120mg"
"00G5W000000MXTvUAO","PLEASE NOTE: Exceptional 6 month coverage of brand Novorapid and Humalog has also been approved. Coverage policy may change with advance notice as compatibility data of insulin pumps and biosimilar insulins becomes available.","","false","false","false","YpsoPump by Yspomed","","","","ypsoPump","","","","9902-0001","","","","","","YpsoPump Insulin Pump"
"00G5W000000MXTlUAO","","","false","false","false","Zepatier","","","","zepatier","","","","9901-0280","","","","50/100mg","","elbasvir/grazoprevir"
"00G5W000000MXTxUAO","","","false","false","false","Zeldox","https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Zeldox_August-14-2008.pdf","https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/prescribers/limited-coverage-drug-program/limited-coverage-drugs-ziprasidone","List with criteria","zip","","tablet","https://pdf.hres.ca/dpd_pm/00056273.PDF","9901-0225","https://www.uptodate.com/contents/ziprasidone-drug-information?search=ziprasidone&source=panel_search_result&selectedTitle=1~54&usage_type=panel&kp_tab=drug_general&display_rank=1","<p>None</p>","<ul><li>Criteria applicable for all plans, including Plan G</li><li>payload includes 9901-0001 (olanzapine)</li><li>This approval includes PharmaCare eligible oral formulations of aripiprazole, brexpiprazole, olanzapine and ziprasidone.</li></ul>","20, 40, 60, 80 mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/ziprasidone.pdf","ziprasidone"
"00G5W000000MiSiUAK","","","false","false","false","Zometa","","","","zometa","","","","9901-0253","","","","4mg/5mL","","zoledronic acid 4mg/5mL"
"00G5W000000MiSiUAK","","","false","false","false","Zonegran","","","","zonisamide100mg","","tablet","","6612-8189","","","","100 mg","","zonisamide capsule 100 mg (SAP)"
"00G5W000000MiSiUAK","","","false","false","false","Zonegran","","","","zonisamide25mg","","tablet","","6612-8188","","","","25 mg","","zonisamide capsule 25 mg (SAP)"
"00G5W000000MiSiUAK","","","false","false","false","Zonegran","","","","zonisamide50mg","","tablet","","6612-8193","","","","50 mg","","zonisamide capsule 50 mg (SAP)"
"00G5W000000MXTxUAO","","","true","true","true","Imovane and generics","","","","zopiclone","","tablet","","9901-0017","","","","3.75mg, 5mg, 7.5mg","https://hlth.sp.gov.bc.ca/sites/HLTHSP/HSIMT/SP/SAT/Shared%20Documents/PDF%20Tech%20Sheets/zopiclone.pdf","zopiclone"
"00G5W000000MXTvUAO","","","false","false","false","Zyban","","","","zybanbupropion","","","","9901-0149","","","","150 mg","","Zyban type bupropion"
